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Abstract
Four experiments were performed in a greenhouse or growth chamber to study the
quantity and quality of flavonolignans in response to environmental stress in milk thistle
(Silybum marianum L., Gaertn.). A preliminary experiment was conducted in spring
2004 to study effects of leaf harvests on growth, development, and flavonolignan content
in milk thistle seeds. Taxifolin, a component of silymarin and precursor to
flavonolignans, was significantly reduced due to leaf harvest treatments.
The weedy nature (sporadic germination) of Silybum made germinating enough
plants for experimentation problematic. Initial germination studies to determine
imbibition and pre-chilling requirements were inconclusive due to heavy fungal
infections. A sterilization procedure was chosen to treat seeds before experimental use
and flavonolignan analysis. Germination trials were also performed with seven other
seed sources. Seeds harvested in Croatia showed the best germination and were used for
subsequent experiments.
Flavonolignans in Silybum seeds are reported to vary depending on environmental
conditions and genetic diversity within a population. In another experiment, total
silymarin concentrations determined from eight seed sources from around the world
ranged from 29.6 to 56.9 mg/gram of seed meal. Individual flavonolignans varied
significantly in and among seed sources.
In the first stress experiment was, plants were grown in pine bark media in
polyethylene bags. Plant densities from 1-24 plants/bag were established. Immature and
iv

total seed counts and yields decreased with increasing density. Number of blooms per
plant, bloom diameter, and mature seed count and yield were negatively correlated to
density. There was no significant effect of plant density on flavonolignan content.
In the second stress experiment, milk thistle plants were grown in perlite in
polyethylene bags. Water treatments (200, 650, 1100, 1550, and 2000 mL/day including
fertigation) were created using pressure-compensated emitters. The lowest watering rate
significantly reduced stem height and bloom diameter. The highest water treatment
showed the highest count of immature seeds. In primary blooms, the lowest water rate
yielded the highest taxifolin concentration (0.89 mg/g). Flavonolignan content was not
significantly affected in secondary blooms.
Silybum growth and development was affected by environmental stress.
However, no significant effect on silymarin concentration or composition was
established.
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I. Introduction
Plants produce a number of secondary metabolite compounds that are not
involved in primary metabolic processes (such as photosynthesis, transpiration, and
respiration). While first thought to be waste products, in reality these compounds serve
various important roles within the plant. Some compounds provide protection for the
plant against herbivory and insect or pathogen attack, while others attract pollinators or
function allelopathically to decrease competition with other plants (Hadacek, 2002).
Secondary metabolites are of great interest not only because of their unique functions
within plants themselves, but also for their potential impact on human health. Many
secondary metabolites, which function for protective purposes in plants, exhibit
antimicrobial or medicinal properties (Bourgaud et al., 2001). Since recorded history,
man has recognized these compounds’ characteristics and has used plants for a variety of
medicinal uses. The levels of secondary metabolites produced in plants can be
environmentally as well as genetically controlled (Singh et al., 2003).
Silybum marianum (L.) Gaertner, also known as milk thistle, is a medicinal plant
containing hepatoprotectant flavonolignans. The flavonolignans in Silybum that exhibit
these medicinal properties are collectively known as silymarin. Originally, silymarin was
thought to be one large, complex molecule. However, in 1974, it was found that
silymarin is actually a mixture of several flavonolignans (Wagner, 1974).
Flavonolignans are formed through the free-radical oxidative coupling of the flavonoid
dihydroquercetin (also called taxifolin), and coniferyl alcohol (a component of lignan)
1

(Kim et al., 2003; Kurkin, 2003). This reaction forms silybin, thought to be the most
bioactive component of silymarin, and a mixture of regioisomers and diastereomers
(Kurkin, 2003). The three main flavonolignans in Silybum are silybin (also referred to as
silybinin), silychristin and silydianin. Furthermore, diastereomers of silybin (silybin A
and B) have been isolated, as well as the regioisomers of silybin, isosilybin A and B (Lee
and Liu, 2003). Most recently, a diastereomer of silychristin (now known as silychristin
A) was discovered and referred to as silychristin B (Martin et al., 2006). Structures of
these compounds can be seen in Figure A-1 (refer to Appendices for all tables and
figures). Other minor compounds include dehydrosilybin, desoxysilychristin,
desoxysilydianin, silybinome, isosilychristin, silymonin, silandrin, silyhermin, and
neosilyhermins A and B. These compounds are found throughout the plant, but are most
concentrated in the seeds. The compounds found in Silybum can act to prevent liver
problems, as well as treat acute liver poisoning or chronic disease. Investigations have
also been made into the use of milk thistle for treating various types of cancer, controlling
cholesterol, promoting nerve system health, and regulating blood sugar in those with type
II diabetes.
The objectives of this research were to determine the individual effects of
population density and water stress on growth, yield, and the quality and quantity of
flavonolignans produced in milk thistle.

2

II. Literature Review
Overview of secondary metabolites
Plants produce a number of secondary metabolic compounds that are not involved
in primary metabolic processes (photosynthesis, transpiration, respiration). These
compounds are formed via biochemical pathways that diverge from primary plant
metabolism. While first thought to be waste products, in reality these compounds serve
various important roles within the plant. Many times these compounds provide
protection for the plant against herbivory and insect or pathogen attack. Others functions
are to attract pollinators or work allelopathically to decrease competition with other
plants (Hadacek, 2002). Secondary metabolites can also protect the plant against UV
radiation and damage. Others function in overflow storage or disposal of waste products
from primary metabolism or are recycled into primary metabolism during leaf
senescence. (Wills et al., 2000) These compounds are essential for plant survival and
reproductive success.
The levels of secondary metabolites produced in plants can be environmentally as
well as genetically controlled (Singh et al., 2003). Secondary metabolites also indicate
differentiation between plant families. For example, Lamiaceae, the mint family,
contains iridoids and essential oils that are not common in other families. Solanaceous
plants contain tropane and steroidal alkaloids. These biochemical variations among plant
families and genera can be attributed in part to phylogenetic and ecological influences.
3

The development of these different combinations of secondary metabolites in plants has
allowed adaptation to and in the environment. (Wink, 2003)
Secondary metabolites are of great research interest not only because of their
unique functions within plants themselves, but also for their potential impact in human
health. Many secondary metabolites that exhibit antimicrobial or medicinal properties
function for protective purposes in plants. (Bourgaud et al., 2001) Most
pharmacologically active secondary plant metabolites are generated from the shikimate,
acetate-malonate, and acetate-mevalonate pathways. Classes of these compounds include
terpenoids (like saponins, carotenoids, and steroids), phenolics (like flavonoids, tannins,
quinines, salicylates, and lignins), alkaloids, polysaccharides, and peptides. Essential oils
and resins are also important and often contain chemicals from multiple classes of
secondary metabolites. (Wills et al., 2000) Man has historically recognized these
compounds’ characteristics and has used plants containing them for medicinal purposes.
Many secondary metabolites are still under-researched as to their potential as medicines
(Singh et al., 2003; Wills et al., 2000).
Medicinal Plants (general)
Written documents from early Chinese, Indian, and Near East cultures indicate
the use of plants as medicine spanning back at least 5,000 years. Perhaps plants have
provided medicine for humans as long as the species has existed. (Hamburger and
Hostettmann, 1991) Today, many commercial drugs have their basis in compounds
discovered in plants. Plants still contain vast potential for the basis of new synthetic
4

drugs, as well as the use of the whole plant or plant parts themselves as medicine. The
past 50 years have seen a great increase in analytical scientific methods for the
investigation of the constituents and biological activity that is found in medicinal plants.
Ethnopharmaceutical and ethnobotanical studies have increased anthropogenic
inspiration for scientific research into the efficacy of these beneficial plants.
Chromatographic (TLC, GC, HPLC), spectroscopic (UV, IR, 1H- and 13C-NMR, MS),
and biological (various bioassays) techniques are used in the growing area of medicinal
plant research. Plants that have received research attention in recent years have
demonstrated anticancer, anti-inflammatory, immunostimulatory, antimicrobial, and
antibiotic properties; furthermore, the potential for continued validation and discovery of
herbal preparations necessitates further research (Phillipson, 2003).
In Germany, the widespread research and use of medicinal plant preparations
(also termed phytopharmaceuticals or phytomedicines) have been common since the
1980’s. Over 300 clinical studies used standardized phytopharmaceuticals, including
Silybum, Echinacea, Aesculus, Hypericum, Ginkgo, Valeriana, Allium sativum, Viscum,
Sabal, Urtica, Crataegus, and Kava-Kava. These studies investigated the use of these
preparations for the treatment of moderate or moderately severe diseases and for the
prevention of disease. Several of the clinical trials showed that the herbal preparations
had full therapeutic equivalence with synthetic drugs without adverse side-effects. The
action of plant extracts vary greatly from the drugs used to treat the same ailments. The

5

action of the herbal preparations can be characterized as polyvalent, and interpreted as
additive or even potentiating. (Wagner, 1999)
Synergistic interactions that occur between compounds in herbal preparations or
phytomedicines are of great importance. Synergism often explains the efficacy of a
preparation, especially when needed in only small doses. The bioactivity, or efficacy, of
one compound in an herbal mixture often decreases when isolated from the mixture. This
is true both in single-plant preparations as well as phytomedicines containing more than
one plant. The use of whole or partially purified extracts containing multiple active
ingredients is essential to the philosophy of herbal medicines. (Williamson, 2001)
Modern Opinion
The medicinal use of herbs by numerous cultures can be found throughout
history. On the North American continent, Native Americans used various herbs for
antifungal, bactericidal, larvicidal, and molluscicidal properties. Extracts of nineteen
plants with reported Native American use were screened for these various bioactivities.
Plants demonstrating bioactivity included Actaea pachypoda, Actaea rubra, Apocynum
androsaemifolium, Aralia hispida, Asarum canadense, Caulophyllum thalictroides,
Gaultheria procumbens, Geocaulon lividum, Ledum groenladicum, Pyrola elliptica,
Sambucus canadensis, Scutellaria epilobifolia, Scutellaria lateriflora, Sorbus americana
(Bergeron et al., 1996). Moreover, many of the native herbs that are commercially
available today were used by Native Americans for similar purposes. Seven of the top
ten most commonly sold herbal supplements in the United States were employed by
Native Americans. These plants include ginseng (Panax quinquefolius, P. ginseng,
6

Eleutherococcus senticosus), garlic (Allium sativum), Echinacea (Echinacea purpurea,
E. angustifolia, E. pallida), goldenseal (Hydrastis canadensis), St. John’s wort
(Hypericum perforatum), evening primrose (Oenothera biennis), and cranberry
(Vaccinium macrocarpon). (Bergeron et al., 1996; Borchers et al., 2000)
Much of the world, especially developing countries, still depends on traditional
medicine or a mix of traditional and Western medicine for the treatment of medical
problems. However, there has been a limited amount of interaction and research
performed to evaluate and compare Western and traditional medicines. The perception
by Western medical practitioners that traditional or herbal medicine is not founded in
science dominates. Nevertheless, interest in herbal medicine is growing along with the
need for Western methodologies to discover new, effective drugs. As was done in the
development of early drugs, researchers are investigating to plants as a source of
medicinal secondary metabolites in an attempt to isolate novel compounds. (Taylor et al.,
2001)
There are several reasons that the population at large is becoming more interested
in natural remedies and herbal medicine. First, consumers are interested in a more
natural way of life. As the world around us becomes more complex, more people desire
to return to their proverbial roots. There has also been an increase in dissatisfaction
among consumers toward modern health care because of expense, undesirable or
dangerous side effects, and ineffectiveness. Finally, as Americans have more leisure
time, more time is spent on one’s health and fitness, especially in a society where aging
7

baby boomers are becoming more concerned with prolonging their health and active
lifestyles. (Brevoort, 1996)
Complementary/alternative medicine (CAM) includes not only herbal medicine,
but also treatments such as acupuncture, reflexology, and chiropractic care. Three
surveys performed in recent years show an increase in use of CAM and an insignificant
increase in healthcare professionals use and knowledge about CAM, specifically herbal
and dietary supplements. In a 2003 study, Madsen et al. conducted a survey of pediatric
patients (age 0-18) profiling CAM use in Denmark. Fifty-three percent of those
interviewed had used CAM at least once, and 23% had tried CAM within the last month
(15% of that consisting of herbal medicines). Fifty percent of patients had experienced
positive effects, with 6% reporting side effects of treatment. The authors note that their
results of 53% of interviewees reporting CAM use is higher than reported in previous
Danish studies and studies from other countries.
Kemper et al. (2003) performed a cross-sectional survey of healthcare
professionals in the Boston, MA area including physicians (MD), advanced practice
nurses (RN), pharmacists (PharmD), and dietitians (RD). 66% of those interviewed
reported receiving professional education about herbs and other dietary supplements
(H/DS) in the past year. However, on the questionnaire about H/DS remedies, the
highest scoring group (dietitians) scored an average of less than 60% of possible points.
Despite the growing knowledge and interest of the consumer/patient for herbal therapies,
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this study indicates that most health care professionals do not have adequate knowledge
of or interest in herbs or other dietary supplements.
A 2007 survey at Georgetown University School of Medicine in Washington D.C.
evaluated first- and second-year medical students’ attitudes toward CAM in their medical
school curriculum and in their future practice In this study, CAM included acupuncture,
herbal medicine, nutritional supplements, biofeedback, bioelectromagnetic therapies,
aromatherapy, homeopathy, chiropractic, massage, hypnosis/guided imagery, music,
prayer/spiritual healing, Rolfing (structural reintegration), therapeutic touch and
meditation. Students indicated that in 11 these of 15 modalities the desired level of
training was “sufficient to advise patients about use,” (Chaterji et al., 2007). The
researchers found that 91% of students agreed that Western medicine could benefit from
ideas and methods included in CAM. More than 85% agreed that “knowledge about
CAM is important to me as a student/future practicing health professional,” and more
than 75% of students thought that CAM should be included in the curriculum (Chaterji et
al., 2007). The highest level of interest was in acupuncture, chiropractic, herbal
medicine, and nutritional supplements. While the students showed interest and
enthusiasm toward CAM, personal experience in the survey group was not highly
prevalent. (Chaterji et al., 2007)
Another problem with herbal medicine currently is the lack of standardization.
This is especially important when considering the increase in self-medication among
individuals who choose to use alternative medicines. (Elvin-Lewis, 2001) Compounding
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the lack of standardization problem is the lack of risk-benefit profiles for herbal
preparations. Risk-benefit profiles can be created by systematic reviews of controlled
clinical trials published using herbal medicines. These profiles include information on
any adverse side-effects of herbs as well as any known contraindications with
prescription drugs. (Ernst, 2002)
Pharmacovigilance is defined as, ‘the study of the safety of marketed drugs under
the practical conditions of clinical usage in large communities,’ (Mann and Andrews,
2002). Pharmacovigilance practices are developed to control the safety and good
manufacturing practices for pharmaceutical drugs. Such standards also need to be
established for herbal preparations. In addition to risk-benefit profiles,
pharmacovigilance monitors adverse drug reactions and responds to and communicates
drug safety concerns. These practices can assist in developing standard methods of
handling plant material for medicine. This is extremely important because the quality
and quantity of medicinal components in plants can be affected by factors including interor intraspecies variation, environmental factors (climate, growing conditions), time of
harvest (can even vary depending on the time of day), and post-harvest factors (storage,
drying, etc.). (Barnes, 2003)
Another important consideration in the use of herbal medicine is potential adverse
interactions with prescription and over-the-counter drugs. For example non-steroidal
anti-inflammatory drugs (NSAIDs), like aspirin, have the potential to increase the risk of
bleeding when taken with herbs that possess antiplatelet activity (such as ginkgo, willow,
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ginger, and garlic) or that contain coumarin (like chamomile and horse chestnut).
Further, acetaminophen when taken with ginkgo can also increase the risk of bleeding
because of decreased platelet aggregation. On its own, acetaminophen has hepatotoxic
properties, and can cause severe liver damage when taken with herbs, like kava-kava and
Echinacea, that can cause stress to the liver. Nephrotoxicity is also possible when
acetaminophen is taken concomitantly with herbs containing salicylate, like willow and
meadowsweet. (Abebe, 2002)
Certain herbs can also decrease the effectiveness of prescription drugs. For
example, St. John’s Wort (Hypericum perforatum) lowers blood concentration of
amitriptyline, cyclosporine, digoxin, indinavir, phenprocoumon, theophylline, and
warfarin. When St. John’s Wort is taken concomitantly with oral contraceptives
(ethinylestradiol/desogestrel), loperamide, or selective serotonin-reuptake inhibitors
(SSRIs), intermenstrual bleeding, delirium, or mild serotonin syndrome can occur. (Izzo
and Ernst, 2001) These sorts of interactions and contraindications are critical to consider
when one chooses to pursue herbal medicine for treatment.
Many medicinal herbs contain antimicrobial properties. One consideration in
using these products is the possibility of increased antibiotic resistance. Ward et al.
(2002) studied the effects of different herbal and nutraceutical products on antibiotic
resistance in gram positive and gram negative bacteria. The minimum inhibitory
concentration (MIC) of antibiotics (ampicillin) applied to the bacteria were recorded in
the presence of the various nutraceuticals preparations. Thirteen of the preparations
11

resulted in an increase in MIC, two preparations showed decreases, and seven had no
changes. Garlic, Echinacea, and zinc products all caused large increases in MIC.
Despite the possible negative or tedious aspects of taking and/or working with
herbal preparations, medicinal phytochemicals can demonstrate several different modes
of health benefits including the following: substrates for biochemical reactions; cofactors
of enzymatic reactions; inhibitors of enzymatic reactions; absorbents or sequestrants that
bind to and eliminate undesirable constituents in the intestine; ligands that agonize or
antagonize cell surface or intracellular receptors; scavengers of reactive or toxic
chemicals; compounds that enhance the absorption and or stability of essential nutrients;
selective growth factors for beneficial gastrointestinal bacteria; and selective inhibitors of
deleterious intestinal bacteria (Dillard and German, 2000).
Silybum – Taxonomy & Culture
Silybum marianum (L.) Gaertner (formally known as Carduus marianus L.) is
classified as follows: Kingdom Plantae, Division Magnoliophyta, Class Magnoliopsida,
Order Asterales, Family Asteraceae, Tribe Cardueae. Silybum can be referred to by the
common names milk thistle, variegated thistle, wild artichoke, lady’s thistle, holy thistle,
Mary thistle, Marian thistle, and St. Mary’s thistle. Several of these common names arise
from the morphology and legend of the plant. Marbled white venation occurs on the
leaves. According to ancient legend, the white venation arose after being touched by the
Virgin Mary’s milk, which also corresponds with the plant’s historical use as a
galactogogue. There are two species in the genus Silybum, the purple flowered S.
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marianum and the white flowered S. eburneum Coss. et Durieux. Both species produce
hepatoprotectant flavonolignans (McKenna et al., 2002). In a genetic study, German
researchers concluded that S. eburneum is really a variation of S. marianum, as opposed
to being a distinct species (Hetz et al., 1995).
Milk thistle grows as an annual or biennial, depending on climate. Leaves are
large, typically growing 10 cm in width and 30 to 40 cm in length. They are obovate
with a cuneate base and undulate, spinose-dentate margins. The leaves are typically a
dark, glossy green with white marbling on the veins. Spines, whose size ranges from 1 to
3 cm, are found both on the leaves and on the seed heads. In the vegetative stage,
Silybum grows in a basal rosette 0.75 to 2 m in diameter. Flowers arise on stems which
can reach 1 m in height in pot production; however, in natural settings milk thistle can
grow taller. The flowers of Silybum are light purple to reddish-purple and range from 2.5
to 6 cm in diameter. The number of flower heads per plant varies greatly, with 9 to 50
flowers being produced on average. Milk thistle seeds grow between 0.5 and 0.8 mm
long, and are wind-dispersed over short distances via 1 to 2 cm pappus crowns. A single
seed head can produce around 100 seeds (Bean, 1985; Morazzoni and Bombardelli,
1995). Milk thistle in the wild has the potential to give rise to an average of 55 seed
heads that can produce some 6,350 seeds per plant (Dodd, 1989).
Ecology & Control
Milk thistle is native to the Mediterranean, and is widespread throughout Europe.
The literature describes milk thistle as synanthropic, or growing in human habitats (Danin
and Yom-Tov, 1990). Wastelands, roadsides, and cultivated ground are all likely places
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to find milk thistle. Areas ranging from the coast to sub-mountainous areas can be
populated by Silybum, with it growing in altitudes of 700 to 1,100 m (McKenna et al.,
2002; Morazzoni and Bombardelli, 1995).
Scientists in Israel have documented seed dispersal by ants and dense plant
occurrence by ant nests. Harvester-ants move the seeds to their nests, remove the
elaiosome (oily body) to feed to their larvae, and deposit the achene in the nutrient-rich
waste area around the ant nest. This nutrient-rich environment promotes germination and
subsequent vigor of the milk thistle plants (Danin and Yom-Tov, 1990; Gabay et al.,
1994).
Due to ease of seed germination and wind-spread seed dispersal, milk thistle is
somewhat invasive in some parts of Europe, Australia, and the United States (Austin et
al., 1988). Invasiveness has been a problem in livestock production, as thick stands of
thistle has the ability to exclude the animals from grazing and cutting off water access
(Auld and Medd, 1987; Dingwall, 1950). Control methods became necessary in these
areas. Control methods including pasture competition, grazing management, slashing,
soil fertility management, chemical controls, and biological controls have been studied
(Dodd, 1989; Sindel, 1991; Souissi et al., 2005; Zheljazkov et al., 2006)
Cultivation
Silybum is most commonly propagated through seed. Milk thistle seeds require
light to germinate, and germinate easily, although sporadically, with moisture.
Germination studies have shown that seeds typically have a dormancy period after
maturation lasting three to six months. (Singh et al., 1982) The normal growing season is
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from early spring to summer, with flower maturation occurring from June to July.
There is nothing in the literature to indicate that S. marianum is photoperiodic. Silybum
can also behave as a biennial (Carrier et al., 2002). Milk thistle is primarily produced in
field cultivation and is generally regarded as having no major insect or disease problems
(Andrzejewska et al., 2006).
In cultivation for medicinal use, seed production and flavonolignan content is of
great importance, as the seeds are commercially used for medicinal preparations. As
previously mentioned, a single milk thistle plant gives rise to numerous seed heads.
Research performed in Argentina in 2002 described some of the trends governing seed
production in milk thistle crops. The number of seeds per plant is affected by the number
of heads per plant. The weight of the seeds per plant is the result of the number of heads
per plant, the number of seeds per head, and the individual seed weight. The number of
seeds per head increases with bloom diameter and decreases with the number of heads
per plant. (Gabucci et al., 2002)
Pook (1983) examined the effect of shade on the growth of milk thistle in a
greenhouse environment during winter. Seedling growth and rate of growth are both
negatively affected by increasing shade. However, increasing shade had minor effects on
seedling morphology until irradiance was reduced to less than 0.20 r.l.i. (relative light
intensity; 20% of full sunlight) at what point leaf expansion and relative growth rates
declined rapidly. Otherwise, seedlings demonstrated high tolerance to shading.
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Other studies have shown that various agricultural conditions can affect the
levels of bioactive compounds (silymarin) in milk thistle. Hammouda et al. (1993)
showed that silymarin levels and individual silymarin components were affected by water
availability and nitrogen levels. The highest silymarin level (63.1% silymarin in an ethyl
acetate extract) was recorded in plants grown at 60% field capacity. Levels of
silychristin, silybin, and isosilybin were also highest at this water level. Silydianin levels
decreased with decreasing water availability. Levels of silymarin in treatments of 75%
and 40% field capacity were similar to levels found in wild plants (45.7%, 45.7%, and
45.6% silymarin in an ethyl acetate extract, respectively). Higher silymarin levels were
observed in nitrogen levels of 100 and 150 kg/feddan (52.2% and 52.8% silymarin in an
ethyl acetate extract; feddan = 1.038 acres).
Warren (2003) also studied Silybum in a greenhouse environment under different
nitrogen concentration. Vegetative yields were affected under different nitrogen
treatments of 47.1 mg/L, 100.6 mg/L, and 151.8 mg/L. The lowest nitrogen treatment
had significantly lower vegetative growth than the other two treatments. Seed yield was
also affected by nitrogen availability. The highest nitrogen concentration yielded 104.7
g/plant, while the lower two concentrations were not significantly different and had an
average yield of 42.1 g/plant. None of the nitrogen treatments significantly affected
silymarin levels in the plants. However, all compounds appeared to increase slightly with
decreasing nitrogen concentrations.
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Silymarin content can also affected by row spacing. Seeds were sown in rows of
two varying widths (25 and 50 cm between rows), and seedlings were thinned to two
plants per hill 30 days after seeding. Narrow row spacing of 25 cm increased the seed
yield, but reduced oil and silymarin content compared to plants grown in rows 50 cm
apart. (Omer et al., 1993)
Silybum – Historical Uses
While initially intimidating due to its spiny nature, Silybum has been historically
used as a food crop. Both the leaves and fruit are edible. The leaves are particularly high
in iron and, when despined, can be eaten in salads or steamed as greens. Fruit can be
toasted and served as a garnish for salad, rice, etc. They can also be roasted and brewed
as a coffee substitute (McKenna et al., 2002).
The use of milk thistle has been documented since the time of Greek philosopher,
Theophrastus, (c.371-287 BCE) who referred to the plant by the name Pternix (Ball and
Kowdley, 2005). Pliny the Elder (23-79 AD) wrote that milk thistle was good for
“carrying off bile,”(quoted in Flora et al., 1998). Dioscorides (40-90 AD), author of de
Materia Medica, described and wrote about milk thistle’s uses, saying a tea of the seeds
could cure poisonous snake bites (Ball and Kowdley, 2005; Flora et al., 1998). By the
16th century, milk thistle was popularly used for hepatobilary diseases (Ball and
Kowdley, 2005). In 1652, prominent English herbalist, Nicholas Culpeper described
milk thistle as an excellent aid “to open the obstructions of the liver and spleen, and
thereby is good against the jaundice,” in his work “The English Physitian” (quoted in
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Ball and Kowdley, 2005). Milk thistle found its way to the Americas with early
European colonists, and in the late 1800’s to early 1900’s the Eclectics, an American
group of herbalist physicians, were using milk thistle for liver, spleen, kidney, and
menstrual problems. In the 1960’s milk thistle research gained new interest in Germany
for the treatment for acute and chronic liver disease, as well as a hepatoprotective agent
to protect against toxic liver injury. (Ball and Kowdley, 2005)
Silybum - Modern Medicinal Use and Research
The compounds found in Silybum can act to prevent liver problems, as well as
treat acute liver poisoning or disease. Investigations have also been made into the use of
milk thistle for treating cancer, controlling cholesterol, promoting nerve system health,
and regulating blood sugar in those with type II diabetes. Some of these studies use the
complex, silymarin, while others use only silybin.
The Liver
The main functions of the liver can be broken down into three categories,
regulation, synthesis, and secretion of substances important to bodily homeostasis.
Nutrients, such as glycogen, and vitamins and minerals are stored by the liver;
furthermore, the liver purifies, transforms, and clears waste products, drugs, and toxins
from the body. The liver also possesses the capability to regenerate lost tissue, and can
maintain its functions, despite moderate damage. However, injury, disease, and ingestion
of toxins can greatly reduce the liver’s ability to carry out its normal activities. Chronic
problems can occur from regular use of common substances like alcohol and
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acetaminophen, and acute distress can occur from ingesting poisonous mushrooms. Cell
damage and impairment of the liver’s capacity are the source of most cases of liver
dysfunction. (Earnest, 2005)
The literature suggests that the medicinal flavonolignans in Silybum work in four
different ways to achieve beneficial effects in the liver. First, they are antioxidants, antiinflammatory, and scavengers and regulators of intracellular glutathione content. This
quality helps explain other benefits outside of the liver. Secondly, the flavonolignans can
behave as cell membrane stabilizers and permeability regulators to prevent hepatotoxic
chemicals from entering liver cells. Thirdly, the compounds have the ability to promote
RNA synthesis, helping to regenerate the liver. Finally, these compounds can inhibit the
transformation of stellate hepatocytes into myofibroblasts, which is the process that leads
to cirrhosis. (Fraschini et al., 2002)
Several reviews have been written in recent years summarizing milk thistle’s use
in the treatment of liver disease. In 2002, Jacobs et al. wrote a systematic review and
meta-analysis on milk thistle for the treatment of liver disease. The group searched for
and compared clinical studies done with milk thistle up until July 1999. (Jacobs et al.,
2002) Two reviews were published in 2005 comparing clinical studies for milk
thistle/silymarin for viral hepatitis and alcoholic liver disease (Ball and Kowdley, 2005).
All of these reviews conclude that due to inconsistencies in dosages of milk thistle,
source of the plant, and other experimental design flaws, no definitive statements can be
made about the use or harm in using milk thistle for liver disease.
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In another review, Rainone (2005) outlines some early studies conducted with
milk thistle for liver disease that had positive, significant effects. In a randomized,
placebo-controlled study, researchers examined 106 patients with mild acute and
subacute liver disease characterized by elevated serum transaminase levels. At the end of
the four week study, of the 97 patients who completed the study, there was a significant
decrease in transaminase levels in the silymarin group. (Salmi and Sarna, 1982)
Ferenci et al. (1989) performed a clinical trial examining the effects of a
standardized milk thistle product (standardized to contain 70 to 80% silymarin) called
Legalon, which is available in Germany and elsewhere in Europe, on cirrhosis. In this
study, 170 patients (46 with alcoholism) were randomized to receive Legalon or placebo
for 24 to 41 months. In the 146 patients who completed the study, a lower mortality rate
was reported in the group who took Legalon. The greatest benefit was found in those
individuals whose cirrhosis was caused by alcoholism and in those whose cirrhosis was
less severe on entry to the study.
In a 1989 double-blind study of 36 patients with chronic alcoholic liver disease,
the patients who were given Legalon for six months showed normalization of bilirubin,
aspartate transaminase and alanine transaminase serum levels. The levels of these liver
enzymes can be used as an indicator of liver health. Patients receiving Legalon also
showed an improvement in histology. These effects were not observed in the placebo
group. (Feher et al., 1989)
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In a 1998 study, 20 patients with chronic active hepatitis were randomized to
receive silybin or placebo. The milk thistle (silybin) group had significantly lower
transaminase, bilirubin, and γ-glutamyltranspeptidase levels than the placebo group. This
study used silybin coupled with phosphatidylcholine, which appears to increase
bioavailability. (Pares et al., 1998) This coupling creates a “phytosome” form known as
silipide or Siliphos® (Hoh et al., 2006; Kidd and Head, 2005). The phosphatidylcholine
is miscible in water and oil/lipid environments, increasing bioavailability. (Kidd and
Head, 2005) This is synthesized by treating an acetone solution of silybin and
phosphatidylcholine with n-hexane in a 1:1 molar ratio. The precipitate is collected and
dried under vacuum. (Ball and Kowdley, 2005)
Cancer
The number of studies using silymarin, silybin, and other milk thistle preparations
for various types of cancer has increased in recent years. Prostate, colorectal, skin, and
mammary cancers have been studied. Effects of silymarin compounds on cancer-causing
factors, like angiogenesis and reactive oxygen species (ROS), have also been studied.
These effects have been studied in cell lines, animal, and human models.
Silymarin and silybin were studied to determine their antiproliferative and
apoptotic effects on rat prostate cancer cells. Both compounds displayed antiproliferative
and apoptotic effects, as well as a strong inhibition of DNA synthesis. Both compounds
worked in a time- and dosage-dependent manner with low toxicity. The authors suggest
that these compounds have the potential to be preventative and therapeutic against
prostate cancer (Tyagi et al., 2002) Silymarin and silybin had cell cycle-inhibitory
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effects in human prostate carcinoma PC3 cells. In this study, silybin and silymarin (50100 µg/mL) inhibited cell proliferation, induced cell death, and cause G1 and G2-M cell
cycle arrest in a time- and dosage-dependent manner. The authors suggested that silybin
was the major active compound, but other stereoisomers (isosilybin A & B, silydianin,
silychristin, and isosilychristin) in the silymarin mixture contribute to its efficacy. (Deep
et al., 2006)
Angiogenesis is known to be associated with tumor growth in the body. Yang et
al. (2003) studied the anti-angiogenic effect of silymarin and silybin compared to the
drug thalidomide in LoVo colon cancer cells. They found that silymarin and silybin
exhibited a comparable, if not better, effect on anti-angiogenesis in the colon cancer cells.
The authors go so far as to suggest silymarin/silybin as an anti-cancer treatment,
especially when considering the extremely low toxicity of silymarin and silybin. In a
2006 pilot study, oral silybin (in the form of silipide) was given to patients with
confirmed colorectal adenocarcinoma at rates of 360, 720, or 1,440 mg silybin daily for 7
days. The authors identified several silybin metabolites and conjugates in plasma and
tissue of the patients at levels similar to known pharmacologic activity levels. While the
levels used in this study did not affect apoptosis and antioxidant markers in the blood, the
treatments were determined as safe and deserving of further study as a human colorectal
cancer chemopreventative agent. (Hoh et al., 2006)
Silymarin and its components have been shown effective against UV damage and
skin cancer. Silybin was evaluated for effect on UV irradiation-induced apoptosis in
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human malignant melanoma cells (A375-S2 cells) by Li et al. Cells were treated with
500 µM silybin for 12 hours. This significantly inhibited UV irradiation-induced
apoptosis in the cells. (Li et al., 2004) In a 2007 study, skin epidermal cell line HaCaT
was used to study UVA-induced damage. UVA-induced oxidative stress was reduced in
a concentration-dependent manner with silymarin concentrations ranging from (0.7-34
mg/L). Silymarin reduced the generation of reactive oxygen species with lead to
inflammation, immunosuppression, photoaging, and photocarcinogenesis. UVA-induced
DNA single strand breaks and caspase-3 activity were also significantly decreased by
silymarin. (Svobodova et al., 2007)
Silymarin has also shown significant anti-inflammatory effects in liver tissue,
exhibiting a number of effects. These include inhibition of neutrophil migration and
Kupffer cells, as well as marked inhibition of leukotriene synthesis and formation of
prostaglandins. While no molecular basis for silymarin’s activity has been established, it
is hypothesized that it might be related to the inhibition of transcription factor NF-κB.
This transcription factor regulates the expression of genes involved in the inflammatory
process, cytoprotection, and carcinogenesis. (Fraschini et al., 2002; Polyak et al., 2007)
Neural Effects
The efficacy of flavonolignans from milk thistle on neurons in culture has also
been studied, suggesting potential benefits these compounds have on the nervous system.
Kittur et al. found that milk thistle seed extract promoted neuronal differentiation,
enhanced nerve grown factor-induced neurite outgrowth and promoted neuron survival in
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PC-12 (pheochromocytoma) cells. Milk thistle extract also prevented oxidative stressinduced cell death in cultured rat primary hippocampal neurons. (Kittur et al., 2002)
The effects of silymarin on brain amines and metabolites were studied using
BALB/c mice. Mice were treated intraperitoneally (into the abdominal cavity lining)
with 0, 10, 50, or 250 mg/kg of silymarin for 5 days. Serotonin levels in the cortex and
dopamine and norepinephrine levels in the cortex were increased in the highest treatment
group. This indicates that silymarin may have slight serotonergic, dopaminergic, and
noradrenergic effects. (Osuchowski et al., 2004)
Type II Diabetes
Silymarin is effective in the treatment of type II diabetes. Oxidative stress can
either cause pancreatic β-cell damage and metabolic abnormalities that can cause or
aggravate diabetes. A 4-month randomized, double-blind clinical trial was performed in
51 patients with type II diabetes. One group received a 200 mg silymarin tablet 3 times a
day plus conventional therapy. The other group received a placebo tablet and the same
conventional therapy. After 4 months, levels of glycosylated hemoglobin, fasting blood
glucose, total cholesterol, low density lipoprotein, triglyceride, SGOT, and SGPT were
significantly lowered in the silymarin group. A slight, but not significant, decrease in
weight, systolic and diastolic blood pressure was found in the silymarin group. The
authors concluded that silymarin does have beneficial effects on the glycemic profile in
individuals with type II diabetes. (Huseini et al., 2006) These results correlate with
earlier studies performed on silymarin as a hypocholesterolaemic drug, its effect on
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cholesterol absorption in rats, and effect on oxidative stress in hypertriglyceridemic rats
(Skottova et al., 2004; Skottova and Krecman, 1998; Sobolova et al., 2006)
Veterinary Applications
Some research has been done using milk thistle in veterinary applications. In a
review of pharmacologic therapies for hepatobilary diseases in dogs and cats, the author
mentions milk thistle as a hepatoprotector with little to no side effects or
contraindications (Sartor and Trepanier, 2003). In a 2004 study, a silymarinphospholipid complex was shown effective in reducing toxicity of aflatoxin B1 in broiler
chickens. Aflatoxin B1 is a mycotoxin commonly associated with animal feed, especially
feeds made with peanuts and cereals. (Tedesco et al., 2004a) Silymarin has also been
beneficial in dairy cows during peripartum, a time where the cows are subject to fatty
liver (Tedesco et al., 2004b). Furthermore, milk thistle silage lowered triglycerides and
liver enzymes in cows, and the silage positively influenced the enzymatic activity of
blood serum in the transition period after calving (Grabowicz et al., 2004).
Silybum – Chemistry & Biosynthesis
The major class of biologically active compounds found in Silybum is known as
flavonolignans. The group of flavonolignans in Silybum that exhibit hepatoprotective
properties is known as silymarin. Silymarin was originally thought to be one large,
complex molecule. However, in 1974, it was found that silymarin is actually a mixture of
several flavonolignans. (Wagner, 1974) Flavonolignans are formed through the freeradical oxidative coupling of the flavonoid dihydroquercetin (also called taxifolin) and
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coniferyl alcohol (a component of lignan) (Kim et al., 2003; Kurkin, 2003) This
reaction forms silybin, thought to be the most bioactive component of silymarin, and a
mixture of regioisomers and diastereomers (stereoisomers that are not mirror images of
one another) (Kurkin, 2003). The three main flavonolignans in Silybum are silybin (also
referred to as silybinin), silychristin and silydianin. Diastereomers of silybin (silybin A
and B) have been isolated, as well as the regioisomer of silybin, isosilybin A and B via
X-ray crystallographic analysis and optical rotation data coupled with 1C and 13H NMR
spectral data (Lee and Liu, 2003). (Figure A-1) Kurkin et al. (2001) achieved the
identification of 2,3-dehydrosilybin with the use of UV and 1H-NMR spectroscopies
(Kurkin et al., 2001). Most recently, a diastereomer of silychristin (now known as
silychristin A) was discovered and referred to as silychristin B (Martin et al., 2006).
Other minor compounds include dehydrosilybin, desoxysilychristin, desoxysilydianin,
silybinome, isosilychristin, silymonin, silandrin, silyhermin, and neosilyhermins A and B.
In addition to the flavonolignans, there are many other compounds of interest in
Silybum. Most recently, two pentacyclic triterpenes were elucidated named silymin A
and B (Ahmed et al., 2007).
Silybum - Extraction
In order to obtain silymarin from milk thistle, the desired compounds must be
extracted from the seeds. The extraction of desired compounds from a solid matrix, such
as plant material, can be thought of as a five step process, and each step of the process
requires careful control for optimization of the overall extraction. These steps include the
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desorption of the compound(s) from the active sites of the matrix, diffusion of the
compound(s) into the matrix itself, solubilization of the analyte in the extractant,
diffusion of the compound in the extractant, and collection of the extracted solutes.
(Camel, 2001; Pawliszyn, 1993) Traditionally, compounds have been extracted using
Soxhlet extraction, sonication, and blending; however, these methods normally require
long extraction times, high solvent use, and low temperatures. Furthermore, these
methods often require subsequent clean-up, concentration, and perhaps filtration of the
desired compounds before analysis. These steps introduce a high probability of loss
and/or contamination of the sample. There are several technologies that have emerged in
the past decade that reduce these problems and ease the optimization of the extraction
process. These technologies include supercritical fluid extraction, pressurized liquid
extraction, and microwave-assisted extraction. (Camel, 2001) All of these methods have
potential for use in milk thistle extraction for analysis.
Current Methodologies
There are many studies that explore the possible methods for silymarin extraction,
and there are several considerations when preparing these extractions. Silymarin
compounds are most highly concentrated in the seeds of milk thistle, and are
hydrophobic. For the most effective silymarin recovery, the seeds should be defatted
prior to extraction. Furthermore, the polarities of the silymarin compounds have a wide
range, with taxifolin being highly polar, to silybin A & B which are only slightly polar.
(Barreto et al., 2003) The solvents, temperatures, and time durations of the extractions all
have to be adjusted accordingly to achieve the most efficient and complete extract.
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Pharmacopoeias call for long extractions using a Soxhlet apparatus. This can be
adapted using series of sonication, vortexing, and centrifugation to achieve complete
extracts. Still, other new technologies have been developed that can maximize the
extraction process.
Supercritical Fluid Extraction
In supercritical fluid extraction (SFE) the extractant (or solvent) is in its
supercritical state, where both temperature and pressure are beyond the critical state of
the solvent. This gives the solvent unique properties of both liquid and gas in that the
viscosity is lower than that of liquid and the diffusion coefficients are higher. This allows
for more efficient extractions. Polarity of the compounds to be extracted is of primary
consideration. (Camel 2001) Pure carbon dioxide (CO2) is the most commonly used
solvent in SFE because of its low critical constants, it is non-toxic, non-flammable, and is
available in high purity at low cost. (Feher et al., 1989) CO2 efficiently extracts nonpolar to low polarity compounds; however, the addition of a modifier solvent to the CO2
is required for effective extraction of mid to highly polar and ionic compounds. (Camel,
2001)
Methanol is commonly used as a modifier in supercritical extraction because if its
miscibility with CO2, and methanol is thought to have the ability to disrupt the bonding
between solutes and plant matrices at high percentages; however, ethanol is also an
attractive modifier as it is less toxic than methanol (Lang and Wai, 2001). Several
studies have been done with the use of ethanol as a modifier. Catchpole et al. (2002)
studied different solvent mixtures for supercritical extractions for four popular herbs, saw
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palmetto, St. John’s wort, kava root, and Echinacea purpurea. While adding ethanol to
the CO2 did increase the yield of compounds from some plants, it also increased
undesirable compounds into the extract, like some color components and high molecular
weight waxes. The supercritical extraction also did not retrieve all the desired chemicals
out of the plant matrices, even with the addition of ethanol to the solvent. For example,
when Echinacea was extracted using both CO2 only and CO2 + ethanol, high levels of
alkamides were extracted, but no chicoric acid or polyphenolics were obtained in the
extract.
Pressurized Liquid Extraction
Pressurized liquid extraction (PLE) is a new technique that has been developed
over the past 10 years. This form of extraction appears under several different names
including accelerated solvent extraction (ASE™, a Dionex trade mark), pressurized fluid
extraction (PFE), pressurized solvent extraction (PSE), or enhanced solvent extraction
(ESE). In this form of extraction, temperature and pressure are elevated, placing the
solvent in a subcritical state, which provides greater mass transfer properties. Elevated
temperature (usually between 100-200 C) allows for a decrease in solvent viscosity, thus
disrupting the solute-matrix interactions and increasing diffusion coefficients more
efficiently. Furthermore, elevated temperatures cause a change in the distribution
coefficients of the desired compounds which allows for greater solubilization into the
solvent. Under these conditions, a complete extract from a sample can typically be
obtained in 5-10 minutes. (Camel, 2001)
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Benthin et al. (1999) investigated the extraction efficiency of pressurized liquid
extraction (PLE) of five various medicinal plant species compared to Pharmacopoeia
monographs (which serve as official standards for the quality control of many medicinal
plants). PLE works on the principle of static extraction with superheated liquids. The
Pharmacopoeia guidelines for milk thistle analysis include a 4 hour Soxhlet extraction in
petrol for defatting, with a subsequent 5 hour Soxhlet extraction with methanol to extract
the flavonolignans. These extracts were compared to PLE extracts which were obtained
in a single extraction cycle using a 5 minute extraction in hexane at 100 C for seed
defatting, followed by a 5 minute extraction in methanol at 100 C. For the extraction of
milk thistle, the group found that the PLE extract yielded slightly higher amount of
flavonolignans in far less time and with five times less solvent consumption than the
Pharmacopoeia guidelines. Overall, the group found that PLE extractions saved a
significant amount of time and solvents for extractions and extracted equal or greater
amounts of the medicinal compounds.
Another exciting possibility for PLE extraction is the option to use hot water as a
solvent. Water is useful in extracting polar compounds, but has the unique capability of
extracting plant material without the necessity of prior defatting. When water is heated
up to its subcritical temperature, there is a decrease in the dielectric constant, or
permittivity. Therefore, water at 250 C has a dielectric constant of 27, which is similar to
that of methanol (33) and ethanol (24), which gives water, at this temperature, solubility
characteristics of these two organic solvents. (Barreto et al., 2003) The temperature of
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water in a PLE cell can be increased over a period of time, and based on the polarities of
the desired compounds in a sample, various compounds will be pulled out of the plant
matrix as the temperature increases. For example, Barreto et al. (2003) demonstrated that
the more polar compounds in a milk thistle seed sample (taxifolin and silychristin) could
be pulled out in a hot water extraction at 85 C and the less polar compounds (silybin A
and B) were extracted at 100 C. Furthermore, they saw an increase in the yield of more
polar compounds in the hot water extraction over the traditional Soxhlet extraction in
ethanol. Finally, the hot water method is also advantageous in that since the solvent used
is water, there is no required, further clean-up of the extract.
Microwave-assisted Extraction
Microwave-assisted extraction (MAE) is another fairly new, effective extraction
method. Microwave radiation is used to heat a solvent-sample mixture. Microwave
energy is non-ionizing and causes molecular motion by migration of ions and rotation of
dipoles. Dipole rotation refers to the alignment of molecules that have dipole moments
(either permanent or induced) in both the solvent and the sample, due to the electric field.
As microwaves are applied to an extraction cell, the molecules go through a cycle of
thermal disorder followed by a re-alignment. This results in rapid heating. This heating
is instantaneous and occurs in the heart of the sample which results in rapid extraction
times. Typically, a solvent is chosen that absorbs microwaves, which allows for heating
of both the sample and solvent; however, for thermolabile compounds, a non-absorbing
solvent can be used which allows the release of compounds into a cold solvent.
Microwave radiation has shown so far to have no degrading effects on extracted
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compounds, unless the temperature in the extraction cell exceeds the temperature ranges
for the compounds. (Camel 2001) Several studies have been done to determine the
effectiveness of MAE on material from various plants, and they have proven that extracts
can be generated in as little at one minute, depending on the plant and solvent used (Huie,
2002).
Silybum analysis
Many advances have been made in screening techniques for medicinal plant
extracts in the past twenty years. Many of the most effective techniques include the use
of high performance liquid chromatography (HPLC) coupled with a detector that has
some capacity for the determination of chemical structure of the components separated by
LC. The benefits arising from the use of LC in these applications is that LC is generally
rapid and does not lead to decomposition, material loss, or artifact formation. Some of
the most recent advances in this area are the coupling of HPLC with UV diode array
detection (LC/UV), mass spectrophotometry (LC/MS), or nuclear magnetic resonance
(LC/NMR). Each of these methods has benefits from the perspective of structure
elucidation and/or identification. (Hostettmann and Marston, 2002)
Minakhmetov et al. (2001) achieved the complete separation, identification, and
quantification of the main flavonolignan constituents from milk thistle seeds. They
discovered the optimum parameters for milk thistle analysis via HPLC. Their mobile
phase was a mixture of acetonitrile and water (27:73 volume %, pH 3.0). Ethanoic acid
was added to the water to reach the desired pH. Through this analysis they were able to
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resolve and identify silybin, silydianin, silychristin, and taxifolin. While a standard of
2,3-dehydrosilybin was used in this study, it was not found as an eluent.
Further studies have employed LC coupled with mass spectrophotometry to
analyze milk thistle samples. Bilia et al. (2001 and 2002) published studies using LC/MS
for the analysis of calendula, milk thistle, and passion flower. The HPLC method used
was very similar to the parameters found by Minakhmetov et al. (2001). Since MS was
used as a detector, the water in the mobile phase was adjusted to a pH of 3.0 using formic
acid. (Bilia et al., 2002; Bilia et al., 2001)
Capillary electrophoresis (CE) is another analytical method that can be utilized
for silymarin analysis. Kvasnicka et al. (2003) compared the analysis of milk thistle via
HPLC to that of CE. They concluded that each method gave comparable results;
however CE did provide for shorter analysis and better resolution of silydianin and
silychristin over the HPLC, which HPLC allowed for the separation of the diastereomers,
isosilybin A and B. Warren (2003) used CE to analyze milk thistle from hydroponic
experiments to determine the effect of nitrogen levels on flavonolignans. Taxifolin,
silybin, and silydianin were identified in these experiments.
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III. Preliminary Study, Germination Tests, and Sterilization Procedure
Abstract
A preliminary experiment was conducted to look at the effect of leaf harvests on
growth, development, and flavonolignan content in milk thistle seeds. Plants grew from
seedling to maturity in approximately four months in a greenhouse environment. The
flavonoid taxifolin, which is a component of silymarin and a precursor to flavonolignans,
was significantly decreased by the harvesting treatments.
Due to the weedy nature of Silybum marianum, there were some unforeseen
obstacles in germinating enough plants to conduct the proposed experiments.
Germination was sporadic, and fungal seed contamination decreased seedling viability.
Germination and sterilization trials were then pursued to determine the most efficient way
to produce viable seedlings for experimentation. Seed germination trials were done in a
growth chamber using Petri dishes with germination paper. Organically grown seeds
from Johnny’s Select Seeds were imbibed overnight and either placed in the chamber or
pre-chilled for one week. Both groups succumbed to fungal infections before
germination data could be collected. Germination trials were also performed with seven
other seed sources including seeds from Frontier Natural Products Co-op (organic and
non-organic seeds), Wild Weeds (two seed lots, one from Oregon and one from Croatia),
Stony Mountain Botanicals, Ltd., and Richters Herbs. The seeds harvested from Croatia
showed the best germination and were used for all subsequent experiments. Also, a
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sterilization procedure using 70% ethanol and a 5% bleach/ 1% SDS solution was
chosen to sterilize seeds before Silybum seeds were sown for experimental use.
Introduction
Preliminary work included growing and harvesting plants in small containers,
performing germination tests on various seed sources, and determining a seed
sterilization technique. The experiment growing plants in small containers occurred first
with seeds from Johnny’s Select Seeds. These germinated rapidly, and a small
preliminary study was done by growing these seedlings in four inch trays. Ten plants
were chosen to have a basal leaf between leaf stages 3-5 removed. Twenty plants were
chosen to have a cauline leaf removed once the flower stem had elongated. Seed was
harvested off of these plants. Seed was also harvested from twenty-four additional plants
that had not had any leaves removed. Growth parameters of stem height and days to
maturity were observed. The harvested seed from all the plants was analyzed for
flavonolignan content.
When subsequent germination attempts were unsuccessful, germination trials
were started. Organically grown seeds from Johnny’s Select Seeds were used in
germination trials in a small growth chamber. Seeds were germinated in Petri dishes with
germination paper. Seeds were imbibed overnight and either put straight into the growth
chamber or pre-chilled at 4 C for one week. These seeds were heavily contaminated with
fungi, affecting germination and seedling viability. With this discovery, a reliable
sterilization technique was sought out. The sterilization procedure used for all
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subsequent experiments consisted of an ethanol wash followed by a bleach/SDS
solution. Further germination trials were performed using seven other seed sources
including seeds from Frontier Natural Products Co-op (organic and non-organic seeds),
Wild Weeds (two seed lots, one from Oregon and one from Croatia), Stony Mountain
Botanicals, Ltd., and Richters Herbs. After all of these initial questions were addressed
and answered, further progress could be made on experiments addressing environmental
stress.
Materials & Methods
Preliminary Study
Seeds from Johnny’s Select (Winslow, ME) were sown into a flat in the
greenhouse. After germination, the seeds were transplanted into four inch polystyrene
Speedling (Speedling, Inc., Sun City, FL) trays in Berger BM1 growth media (Berger
Peat Moss, Quebec, Canada) and grown to maturity. (Figure A-2) A one hundred mg/L
solution of 20-9-17 (N-P-K) fertilizer was applied once a week starting three weeks after
transplanting. Plants were chosen at random to undergo two leaf harvests. One harvest
was performed on ten plants during the basal growth period (treatment 1). In this harvest,
one small, healthy leaf between true leaf stages 3-5 was removed. The second leaf
harvest of cauline leaves was performed on another twenty randomly chosen plants
(treatment 2). One leaf off of the flowering stem was chosen. One plant did appear in
both random leaf harvest selections. As the flowers matured, cloth, drawstring bags (10 x
15 cm; Consolidated Plastics Co., Inc., Twinsburg, OH) were placed over the seed heads
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to prevent loss of seeds, as the seed heads open at maturity and seeds are dispersed via
wind with the pappus attached to each seed. Mature seeds were harvested from all the
plants that had experienced a leaf harvest. An additional random selection of twenty-five
plants that had experienced no leaf harvesting was chosen for seed harvest (treatment 3).
The seeds were harvested off the remainder of the plants and bulked. At the time of seed
harvest, growth data was recorded, including stem height, mature seed weight and
number, immature seed weight and number, and days to maturity. Seeds were stored at 4
C until analysis. Growth and yield parameters were analyzed using mixed model
ANOVA and LSD means separation, on a complete random design (CRD) using SAS
(SAS Institute, Inc., Cary, NC).
For analysis, seeds were sterilized using 70% ethanol followed by a 5%
bleach/1% sodium dodecyl sulfate (SDS) solution. (Procedure D-1) The seeds were
allowed to dry and then were ground with a coffee mill. For flavonolignan extraction,
100 mg Silybum seed meal was sonicated with petroleum ether for 30 min for defatting.
This was followed by a triple extraction with methanol. After each methanol addition,
the samples were sonicated for 20 min. The aliquots from each methanol extraction were
pooled and evaporated to dryness under a nitrogen stream. Samples were then
redissolved in 1.0 mL of methanol and 100 µL of 1.0 mg/mL hesperetin internal standard
was added. This mixture was filtered through a 0.45 µm syringe filter into 2 ml crimptop HPLC sample vials. (Procedure D-2) Extracts were analyzed for flavonolignan
content with an Agilent 1100 HPLC (Agilent Technologies, Santa Clara, CA) equipped
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with a diode array detector (DAD), and a Luna C-18(2) (250 x 4.6 mm, 5 µm) column
(Phenomenex, Torrance, CA) using a method adapted from Wallace et al. (2003). The
column was held at 40 C. The injection volume was 25 µL. Mobile phase A consisted of
a 20:80 methanol: water solution, and mobile phase B consisted of an 80:20 methanol:
water solution. The solvent gradient started with an 85:15 mixture of mobile phases A
and B for 5 min. Over the next 15 min, the gradient changed linearly to 45:55 (solvent A:
solvent B) and was held constant for 15 min. The ratio then changed linearly to 0:100
(solvent A: solvent B) over 3 min. This was held constant for 5 min. The gradient then
changed linearly over 1 min to the original ratio of 85:15 (solvent A: solvent B) for a
total run time of 44 min. (Table B-1) The flow rate for the gradient program was held
constant at 0.8 mL/min. (Procedure D-3) Flavonolignan quantities are reported in mg of
compound per g of seed (mg/g). (Procedure D-4) Mixed model ANOVA with LSD
means separation, using a complete random design (CRD) with sampling, was performed
using SAS to analyze flavonolignan content (SAS Institute, Inc., Cary, NC).
Initial Germination Study
Seed germination was studied due to poor germination that occurred after the
preliminary experiment. Organically grown Silybum marianum seeds were obtained
from Johnny’s Select Seeds. Initial attempts at germinating seeds for subsequent studies
were unsuccessful and inconsistent with the germination rate reported by the seed
company. Therefore, germination techniques were studied.
A small growth chamber (Model E-30B; Percival Scientific, Perry, IA) was
programmed for 16 hours of dark at 20 C and 8 hours of light (photosynthetic photon flux
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of 300 µmol m-2 s-1) at 26 C. Five Petri dishes were prepared containing moistened
germination paper and twenty seeds per plate. The dishes were placed in the growth
chamber with the lid askew as to prevent evaporation of the water and overheating of the
seeds. Another five groups of twenty seeds were subjected to a pre-chilling method as
described by the Seed Lab Manager at Johnny’s Select Seeds (Norma Rossel, personal
communication). These plates were prepared as previously described with the addition of
a one week pre-chilling period at 4 C.
A similar trial was performed on various seed sources to determine which seed
source was the most reliable to use for the environmental stress experiments. Seven seed
sources were obtained including the following: Johnny’s Select Seeds, Frontier Natural
Products Co-op (Norway, IA), Frontier Natural Products Co-op (organically grown),
Wild Weeds (Blue Lake, CA) (grown in Oregon), Wild Weeds (grown in Croatia), Stony
Mountain Botanicals Ltd. (Loudonville, OH), and Richters Herbs (Ontario, Canada).
Surface Sterilization Technique
Sterilization was deemed necessary after viewing the results from controlled
germination. Seeds were subjected to a treatment with 5% bleach for five min washed
off with water three times. The seeds were then grown on Petri dishes in the manner
previously described, again comparing a pre-chilled group to a group placed directly in
the growth chamber. When fungal growth was still prevalent, a more aggressive
sterilization procedure was sought. The method used for the remainder of the studies
involved washing the seeds for two minutes in a 70% ethanol mixture, rinsing the seeds,
placing them in a 5% bleach/95%water/1% sodium dodecyl sulfate (SDS) solution for
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fifteen minutes, and thoroughly rinsing the seeds with water. (Procedure D-1) This
method was used for seeds prior to germination, as well as harvested seeds from
subsequent experiments previous to grinding and analysis.
Results
Preliminary Study
Average stem height, number and weight of mature seeds per plant, and total
number and weight of seeds per plant were significantly affected by leaf harvest
treatments. (Table B-2) Average stem heights were 26.0 cm, 25.0 cm, and 32.6 cm for
the basal leaf removal, the cauline leaf removal, and no leaves removed, respectively.
The height of plants with no leaves removed varied significantly from the other two
treatments (P<0.05). (Table A-3) Similarly, the number of mature seeds harvested from
plants that had had no leaves removed was significantly greater than the two treatments
where leaves were removed (P<0.05). Seeds counts for treatments 1, 2, and 3 were 16,
13, and 22 seeds/plant, respectively. (Table A-4) The weight of mature seeds for
treatments 1, 2, and 3 were 0.399, 0.319, and 0.621 g/plant, respectively, with the weight
of treatment 3 varying significantly (P<0.05). Total seed weights were 0.432, 0.340, and
0.654 g/plant, respectively. (Table A-5) Again, the plants that had no leaves removed
were significantly different than the other two treatments (P<0.05).
Mixed model ANOVA analysis showed that only the levels of taxifolin were
significantly affected by the leaf removal treatments. All other flavonolignans were not
significantly affected by treatments. (Table B-3) The seed-only treatment contained 1.43
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mg taxifolin/g of seed meal, while the leaf removal treatments yielded an average of
0.97 mg/g taxifolin. While the flavonolignans were not overall affected by the treatment,
LSD means separation did find some significance between certain treatments.
Silychristin levels indicated a difference between seed-only harvest and basal leaf harvest
(P<0.05), with average concentrations of 4.48 and 3.32 mg/g, respectively. (Figure A-6)
Total silymarin concentrations also showed differences between seed only harvest and
basal leaf harvest, with average silymarin concentrations of 30.73 and 25.19 mg/g,
respectively. (FigureA-7 and Table B-3)
Unknown compounds 3, 4, and 7 were also significantly affected at P<0.05.
(Table B-4) For unknown 3, cauline leaf and seed only harvests were significantly
greater than the basal leaf harvest. The concentration of unknown 4 was highest in the
seed-only harvest and lowest in the cauline leaf harvest. Unknown 7 concentrations were
highest in the cauline leaf harvest treatment and lowest in the basal leaf and seed-only
harvests. (Figure A-8 and Table B-4)
Initial Germination Study
Seeds that were placed in the growth chamber with no pre-chilling treatment
started to show signs of fungal infection within four days placement into the growth
chamber. The fungi appeared to be most concentrated around the area of radicle
emergence from the seed. When seeds subjected to the pre-chilling treatment were
observed, fungal growth was already apparent, despite the cold conditions. Both groups
showed germination. However, the prevalence of the fungal growth overtook the radicle
in many cases. Germination could not be considered successful in most cases.
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The germination trials performed with the seven seed sources determined that
the Wild Weeds (Croatia) source demonstrated the highest level of germination and
dependability. These seeds were used for all the subsequent environmental stress
experiments.
Discussion
Preliminary Study
The growth and yield data from this study suggested that the removal of
vegetative growth from milk thistle has significant effects on total plant growth and seed
development. Possibly, these results are exaggerated in this study because of the
confined growing space these plants were subjected to. From observation, these plants
did not produce the amount of foliage that is typical for this plant when grown in the field
or large, hydroponic bags in the greenhouse. Therefore, the removal of any vegetative
growth limited the plants accumulation of photoassimilates, limiting the available
resources for further growth and secondary metabolite production.
While there was no difference in the production of individual silymarin
components among the treatments, the total amount of silymarin produced was
significantly higher in the plants with no leaves removed than the plants that had a basal
leaf removed. This suggested that early removal of vegetative material significantly
affected that amount of flavonolignans that were yielded at seed maturity.
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Initial Germination Study
Milk thistle is a weedy species, and one successful trait that many weeds possess
is sporadic germination. This allows for stronger success for a wild population to
reproduce to the next generation, as the entire seed bank is not destroyed by one
devastating event, such as a severe drought. (Dodd, 1989; Groves and Kaye, 1989) Milk
thistle is also known to germinate at a much lower rate soon after the seeds reach
maturity. After a “curing” period of usually 3-6 months, germination improves. Actual
age of the seeds from various sources was unknown, therefore, the possibility remains
that the seeds had not yet reached their maximum potential for germination.
Furthermore, the seeds from Johnny’s Select that were used in the initial leaf
harvest study had been in cool storage since 2001, so it stands to reason that these seeds
were indeed more prepared to germinate than newer seeds also obtained from Johnny’s
Select as well as other seed sources.
Initial germination studies were riddled with fungal problems and poor
germination. Surface sterilization was a partial cure for the fungal problem. However,
seeds still did not germinate when given recommended light and moisture
recommendations. The probability exists that these seeds were still not physiologically
mature enough to achieve high germination rates or the fungi had weakened seed
viability.
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IV. Flavonolignan Content of Various Seed Sources
Abstract
Flavonolignan in milk thistle have been shown to vary depending on the climate
in which the plants were grown and genetic diversity within a population. This study
looked at the silymarin levels in seeds from eight seed sources from around the world.
Tested seeds were grown in Oregon, Croatia, Serbia, and various parts of the midwest
United States and Europe. All flavonolignans were significantly different in each seed
source. Total silymarin concentrations ranged from 56.9 mg/g of seed meal in seeds from
Stony Mountain Botanicals to 29.6 mg/g of seed meal in seeds from Johnny’s Selected
Seeds.
Introduction
The levels of flavonolignans in Silybum have been shown to differ when plants
are grown in varying climates (Kurkin, 2003). Seeds were obtained from eight different
seed sources around the world. Geographic areas covered include the midwest United
States, Oregon, Croatia, Serbia, and Europe. Samples from each of the seed sources were
extracted and analyzed by HPLC to observe the differences in silymarin profiles from
each geographic area.
Materials & Methods
Seeds were obtained from Frontier Natural Products Co-op (organically and nonorganically grown lots), Johnny’s Select Seeds, Wild Weeds (seeds lots grown in Croatia
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and Oregon), University of Belgrade, Stony Mountain Botanicals, Ltd., and Richters
Herbs. Seeds were sterilized, ground to 20 mesh, extracted once with petroleum ether for
defatting, and extracted in triplicate with methanol for flavonolignan analysis.
(Procedures D-1 – D-4) Analysis was performed on an Agilent 1100 HPLC equipped
with a DAD detector as detailed in Chapter III. Flavonolignan levels were statistically
analyzed in a CRD using mixed model ANOVA and Tukey means separation.
Results
All silymarin components and unknown compounds were significantly affected
by the seed source. (Table B-5 and B-6) Tukey means separation did show differences in
compounds between seed sources. (Figure A-9) Seeds obtained from Stony Mountain
Botanicals, Ltd. (SM) and Frontier Natural Products Co-op (F) yielded the highest total
silymarin concentration at 56.90 and 51.41 mg/g of seed meal, respectively. The lowest
concentration of 29.6 mg/g silymarin was found in the seeds from Johnny’s Select Seeds.
(Figure A-11) Varying seed sources also had different flavonolignan profiles. (Figure A10) The silymarin profiles of SM and F seeds also had the highest concentrations of
silybin A & B.
Discussion
This analysis confirms the great variability in flavonolignan content that exists in
milk thistle plants. Kurkin (2003) speaks of milk thistle grown in Yugoslavia, Bulgaria,
various parts of Russia, Hungary, and Sweden varying in the ratios of individual
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flavonolignans in the silymarin complex. Seeds from plants grown in Russia had a 3:1
ratio of silybin to silydianin. Seeds harvested in Yugoslavia had 10:4:1 ratio of silybin to
silydianin to silychristin. Silydianin was the primary compound in seeds grown in
Ukraine. Plants from Sweden also had higher concentrations of silydianin than silybin.
In this seed source analysis, the SM and F seed sources contained the highest total
silymarin content as well as the highest content of silybin A & B. Silybin is commonly
regarded as the most bioactive constituent of silymarin (Crocenzi and Roma, 2006).
However, silydianin was present in the highest concentrations across all seed sources
analyzed here. Some of the sources, like Frontier Natural Products Co-op, sell milk
thistle seeds for dietary supplementation, not necessarily for reproduction of the plant.
This reiterates the importance in quality control in herbs when growing plants for
medicinal extracts.
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V. Population Density Effects on Growth, Yield, and Flavonolignan
Production
Abstract
Milk thistle, Silybum marianum (L.) Gaertn., is grown throughout the world for its
hepatoprotectant flavonolignans, known collectively as silymarin. Silymarin is found
primarily in the seeds. Milk thistle was grown in a controlled environment (16 hours of
light at 1200 µmol/m2/s and 23 C and 8 hours of dark at 16 C) for determination of plant
growth, seed yield, and flavonolignan content under various levels of population density
stress (ranging from 1 to 24 plants per container). Total seed count per plant (ranging
from 0-293) and yield (ranging from 0.0-4.3 g) decreased with increasing population
density; furthermore, the count and yield of malformed or immature seed also decreased
with increasing density. Additionally, the number of blooms per plant, bloom diameter,
and mature seed count and yield were negatively correlated to density. There was no
significant effect of population density on flavonolignan content.
Introduction
Milk thistle is a medicinal plant whose use has been documented since ancient
times as a treatment for liver and bile-related diseases, as well as acute Amanita
mushroom poisoning (Fraschini et al., 2002; Kurkin, 2003). Current studies have
explored milk thistle’s use against various types of cancer, for cholesterol control, and for
blood sugar control in those with type II diabetes (Gazak et al., 2007; Huseini et al.,
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2006). Many of these benefits are attributed to the phenolic content of the plant’s leaves
and seeds, which, like many secondary metabolites, are known to be affected by biotic
and abiotic stress (Beckman, 2000; Sudha and Ravishankar, 2002). The seeds contain a
group of hepatoprotectant phenolic compounds known as flavonolignans.
Flavonolignans are formed from a coupling of a flavonoid, taxifolin (dihydroquercetin),
and a phenylpropanoid lignan component, coniferyl alcohol. The primary bioactive
flavonolignans include silybin A, silybin B, isosilybin A, isosilybin B, silychristin, and
silydianin. These compounds, along with taxifolin comprise the hepatoprotectant
complex called silymarin.
Since these valuable medicinal compounds are found primarily in the seeds,
factors regulating seed production in milk thistle crops are important. The relationship
among blooms (or heads) and seed weight and count were described by Gabucci et al.
(2002). The number of seeds per plant was positively correlated to the number of heads
per plant. The weight of the seeds per plant was positively correlated to the number of
heads per plant, the number of seeds per head, and the individual seed weight. In
addition, the number of seeds per head increased with bloom diameter and decreased with
the number of heads per plant.
Population density and row spacing have been shown to have significant effects
on the growth, yield, and flavonolignan concentrations in milk thistle. Austin et al.
(1988) showed that milk thistle harvested 6 weeks after planting had the highest shoot
yield when planted at a density of 8 plants/pot (pot diameter = 18 cm). At the next
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density of 16 plants/pot, shoot yield began to decrease. Omer et al. (1993) found that a
narrow row spacing of 25 cm produced higher seed yields in milk thistle but lower oil
and flavonolignan content compared to a wide row spacing of 50 cm. Concentrations of
silybin, silychristin, isosilybin, and silymarin were all significantly higher in the wider
row spacing than the 25 cm row spacing.
The objectives of this experiment were three-fold. The first was to examine the
effect of population density on plant growth and seed yield of milk thistle. The second
was to determine if population density stress affects the quality and quantity of silymarin
in the seeds, and the third was to determine an optimum population density for seed and
flavonolignan yield.
Materials & Methods
Plants were grown in 19 L (0.02 m3) poly grow bags (Hydro-Gardens, Colorado
Springs, CO) in pine bark media (SunGro Horticulture, Bellvue, WA) with 15 mL (15.67
g) 14-6-12 (N-P-K) Osmocote (Scotts-Sierra Horticultural Products Co., Marysville,
OH). Population density treatments were based on the number of seedlings planted per
bag. Densities were 1, 2, 4, 8, 12, 16, 20 and 24 plants per bag. Bags were arranged in a
randomized complete block (RCB) design consisting of two blocks with each treatment
represented once per block. (Figures A-12 and A-13) The plants were grown to maturity
in a growth chamber with 16 hours of light at 1200 µmol/m2/s and 23 C and 8 hours of
dark at 16 C. Blooms were covered with drawstring bags post-anthesis. At maturity the
blooms were harvested, and growth data including blooms per plant, bloom diameter,
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days to maturity, stem height, mature and immature seed number and weight were
collected (Figure A-14). Seed were stored at 4 C until analysis.
Seed preparation and analysis was performed as detailed in Chapter III.
(Procedures D-1 – D-4) Growth and yield data, as well as flavonolignan and unknown
compound concentrations were analyzed using simple linear regression, with the
exception of bloom diameter which was analyzed with quadratic regression. Statistical
analysis was performed using SAS.
Results
All regression analyses were calculated using the actual numbers of plants
harvested in each container. Mortality was high in some of the original planned
treatment densities, which resulted in different numbers of plants per container (Table B7). Analysis showed a normal distribution of all growth and yield parameters against the
treatments. The number of blooms per plant (R2=0.43), bloom diameter (R2=0.59),
number and weight of mature seeds (R2=0.54 and R2=0.53, respectively), number and
weight of immature seeds (R2=0.43 and R2=0.29) and total number and weight of seeds
(R2=0.62 and R2=0.55, respectively) were negatively correlated to plant density (P<0.05).
(Figures A-15 – A-18) All components of silymarin (taxifolin, silychristin, silydianin,
silybin A and B, and isosilybin A and B) and unknown compounds were normally
distributed. However, none were significantly affected by population densities. (Table B8 & B-9) Total levels of silymarin in seeds varied with population density, but not
significantly (Figure A-19).
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Discussion
From this study it was concluded that increasing population density did not affect
the quantity and quality of flavonolignans. Decreased yield and overall plant vigor
occurred when milk thistle was grown in high density conditions. The decreased seed
yields and numbers were consistent with lower bloom diameters and number of blooms
per plant, as was previously described by Gabucci et al. (2002). However, these findings
disagree with seed yields and flavonolignan effects reported by Omer et al. (1993).
Further research in this area could include population density effects in a field setting
where root growth is not as restricted as in this experiment, and plants are exposed to
sunlight as opposed to artificial light.
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VI. Daily Water Rate Effects on Growth, Yield, and Flavonolignan
Production
Abstract
Milk thistle, Silybum marianum (L.) Gaertn., is a medicinal plant, grown
worldwide, that contains hepatoprotectant phenolic compounds known as flavonolignans.
These compounds are found primarily in the seeds and are collectively known as
silymarin. This study examined the effects of water stress on plant growth, seed yield,
and flavonolignan content in milk thistle. Plants were hydroponically grown under
greenhouse conditions with varying daily water rates (200, 650, 1100, 1550, and 2000
mL/day). The lowest watering rate significantly reduced stem height (40.8 cm) and
bloom diameter (2.3 cm). The 1550 mL/day treatment had the highest stem height at
106.3 cm, and the 1100 mL/day treatment had the largest bloom diameter at 2.9 cm. The
highest water treatment also showed the highest count of malformed or immature seeds
(161 seeds/plant). The 650 mL/day treatment had the lowest number of immature seeds
with 62 seeds/plant. The primary blooms were analyzed separately from the secondary
blooms for flavonolignan content. In primary blooms, the lowest water rate yielded the
highest concentration of taxifolin (0.89 mg/g of seed meal). In secondary blooms,
flavonolignan content was not significantly affected.
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Introduction
Milk thistle grows worldwide and its use has been documented since ancient
times as a treatment for liver and bile-related diseases, as well as acute Amanita
mushroom poisoning (Fraschini et al., 2002; Kurkin, 2003). In addition to
antihepatotoxic actions, current studies have explored milk thistle’s use against various
types of cancer, for cholesterol control, and for blood sugar control in those with type II
diabetes (Gazak et al., 2007; Huseini et al., 2006). The phenolic content of the plant’s
leaves and seeds have been associated with these benefits. Like many secondary
metabolites, phenolics are known to be affected by biotic and abiotic stress (Beckman,
2000; Sudha and Ravishankar, 2002). Concentrated in the seeds are a group of
hepatoprotectant phenolic compounds known as flavonolignans. Flavonolignans are
formed from the coupling of a flavonoid, taxifolin (dihydroquercetin), and a
phenylpropanoid lignan component, coniferyl alcohol. The primary bioactive
flavonolignans include silybin A, silybin B, isosilybin A, isosilybin B, silychristin, and
silydianin. These compounds, along with taxifolin, comprise the hepatoprotectant
complex known as silymarin.
Silymarin levels have been documented to be affected by water availability.
Hammouda et al. (1993) showed that silymarin levels were higher in plants grown at 60%
field capacity compared to wild harvested plants. Silydianin also decreased in plants
grown under lower water conditions.
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The objectives of this study were: 1) to examine the effects of water stress on
plant growth and seed yield of milk thistle and the quality and quantity of silymarin in the
seeds; and 2) to determine the irrigation rate needed to optimize seed yield and
flavonolignan content.
Materials & Methods
This experiment was conducted in the greenhouse in 0.02 m3 poly grow bags
(Hydro-Gardens, Colorado Springs, CO) filled with perlite. Plants, planted one per bag,
were subjected to five different watering regimes. This experiment was set up in a
randomized complete block (RCB) with four blocks to account for variation across the
greenhouse. Each block contained two single plant replications of each of the five
watering treatments. (Figure A-20) The treatments were controlled using spray irrigation
emitters of different rates. There was also an emitter in each bag that emitted a
fertigation solution at a rate of 100 mL/day. The fertigate was a mixture of 25% ChemGro 4-8-31 (N-P-K) (Hydro-Gardens, Inc., Colorado Springs, CO), 25% fertilizer grade
CaNO3, and 12.5% MgSO4. (Table B-10) This mixture was further diluted with water to
a ratio of 1:100 using fertilizer injectors. Plants received 10.2 mg of nitrogen, 4.09 mg of
phosphorus, and 16.4 mg of potassium per day. The watering rates were as follows:
2000, 1550, 1100, 650 and 200 mL/day (these rates include 100 mL of fertigation per
day). The plants grew and developed in this hydroponic system until flowering. (Figure
A-21) Cloth, drawstring bags were placed over the blooms as post-anthesis. At maturity
the blooms were harvested, and growth data including blooms per plant, bloom diameter,
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days to maturity, stem height, mature and immature seed number and weight were
collected. Primary blooms from each plant were analyzed separately from all secondary
blooms. Secondary blooms were grouped together from each plant for analysis. Seeds
were stored at 4 C until analysis.
Seeds were sterilized before starting extractions and analysis. (Procedure D-1)
Extraction and analysis was performed as detailed in Chapter III. (Procedures D-2 – D-4)
Statistical analysis was performed using SAS. Growth and yield data, as well as
flavonolignan and unknown compound concentrations were analyzed using mixed model
ANOVA and LSD means separation. SAS was used for all statistical analyses.
Results
Growth and yield data were analyzed using a RCB with replication model.
Parameters of bloom diameter, stem height, and count of immature seeds were
significantly affected by water treatments according to LSD means separation (P<0.05).
Bloom diameter was smallest, at an average of 2.3 cm, in the 200 mL/day treatment and
greatest in the 1100 mL/day treatment, with an average of 2.9 cm. The other treatments
did not change bloom diameter significantly from the 1100 mL/day treatment. (Figure A23) Stem height was significant in the ANOVA analysis (P=0.0005) as well as mean
separation. Stems were shortest, at 40.8 cm, in the 200 mL/day treatment. The 650 and
2000 mL/day were statistically the same with an average stem height of 71.5 cm. The
1100 and 1550 mL/day treatments were also statistically the same with an average height
of 123.3 cm. (Figure A-22 & Table B-12) The immature seed count was also affected by
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water treatments. The 2000 mL/day treatment was significantly different from the 1550
and 650 mL/day treatment (averages were 161 and 63 immature seeds per plant,
respectively). The other treatments did not differ and had an average of 84 immature
seeds per plant. (Figure A-24) Yield data was not significant. (Table B-11)
Primary and secondary blooms were analyzed for flavonolignan content using a
RCB with replication and sampling. In primary blooms, taxifolin concentrations were
significantly affected with the highest concentration (0.89 mg/g) in the 200 mL/day
treatment and the lowest concentration (0.47 mg/g) in the 650 mL/day treatment. The
other treatments did not differ significantly from each other and had an average taxifolin
concentration of 0.64 mg/g. (Figure A-25) Water level did not significantly affect
flavonolignans in secondary blooms. Water level did not significantly influence
silymarin content in primary or secondary blooms. (Figures A-26 and A-27)
Discussion
Plant growth and secondary metabolite concentrations have been documented to
be affected by water stress. In a study of Japanese mint (Mentha arvensis), researchers
found that water stress, from unstressed levels to acute stress levels, reduced plant height
(51.5 to 39.7 cm, respectively) and leaf length (4.8 to 3.5, respectively). Terpenoid
essential oil levels (menthol, menthone, and methyl acetate) were highest at mild stress
levels (30% field moisture capacity) at 0.58% fresh weight. Essential oil levels were
significantly lowered by acute water stress (10% field moisture capacity) to 0.40% fresh
weight. (Misra and Srivastava, 2000)
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From this study it was concluded that different daily water rates has minimal
effect on the quantity and quality of flavonolignans in milk thistle. The minor growth
differences observed between treatments and the lack of effect on days for plants to reach
maturity suggest that conditions of true water stress were not reached in this experiment.
Cell growth has been determined to be the first process that declines when a plant
undergoes water stress. Closely related to growth in being restricted by water stress is
cell division. (Hsiao et al., 1976) These processes were slowed in the lowest water
treatment, as stem height and bloom diameter were affected. While the lowest water rate
did affect stem height and bloom diameter, it had no effect on mature seed count or yield.
Therefore, the lowest water treatment did not have a major effect on overall plant vigor.
The results indicated that milk thistle can be grown with minimal input of water without
decreasing yield or flavonolignan content.
Furthermore, the literature suggests that milk thistle is not susceptible to many
insect and disease pressures in field production. While this may be true, in greenhouse
production insect pressure was great. White flies and aphids were both troublesome.
(Figure A-28)
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VII. Summary & Overall Conclusions
Flavonolignan Content
Growth and yield of milk thistle was affected, typically reduced, with increasing
stress. However, flavonolignan concentrations were largely unaffected by environmental
stresses studied here. From a production standpoint, flavonolignan content per plant or
per unit area may be a more useful calculation. Despite reduction in overall growth or
yield, silymarin content produced per unit area (in these experiments unit area = 4 ft2 =
0.37 m2) may be increased.
When silymarin content was calculated for the preliminary experiment with the
data from the three leaf removal treatments, basal leaf removal yielded 362 mg/4 ft2.
Cauline leaf removal yielded 334 mg/4 ft2, and the plants with no leaves removed yielded
687 mg/4 ft2. These plants were grown in 4” Speedling trays, therefore, a 4 ft2 area
represents 36 plants.
In the population density study, flavonolignan content varied from 29.0 mg/bag (6
plants/bag) to 285 mg/bag (12 plants/bag). The median content was 147 mg/bag (11
plants/bag). Each bag represents roughly 4 ft2 (this includes the bag diameter of 1 ft plus
1 ft spacing between bags).
Content calculations for the water experiment resulted in the following results:
200 mL/day had 204 mg/bag, 650 mL/day had 238 mg/bag, 1100 mL/day had 530
mg/bag, 1550 mL/day had 585 mg/bag, and 2000 mL/day had 391 mg/bag. Again, each
bag plus spacing between bags is 4 ft2.
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In the water stress experiment, the time from planting to harvest was
approximately one year. The preliminary experiment reached maturity in approximately
four months. If milk thistle plants grown in small containers could be harvested every
four months, it would be possible to reach a total silymarin yield of 2061 mg/4 ft2/year.
This surpasses the yield potential of plants under any of the water stress treatments.
Other Considerations
UV Light
Flavonolignans in milk thistle were not significantly affected by population
density or water stress. Several concepts may explain the lack of significant effects.
Flavonolignans may function in the plant to protect from UV radiation. In human
keratinocytes, silymarin has shown to reduce UVA-induced damage by reducing the
amount of reactive oxygen species formed and reducing lipid peroxidation. (Svobodova
et al., 2007) Silymarin could function in similar ways in plant cells as well. To study
population density and water stress, plants were grown in greenhouses and growth
chambers. Neither of these controlled environments have high incidence of UV light.
The absence of UV light may have reduced the amount of flavonolignans formed.
Conjugated Flavonolignans
Warren (2003) found bioactivity in milk thistle roots, stems, and leaves in the
potato disk bioassay, but CE analysis did not detect pure flavonolignan compounds in
these vegetative extracts. Other studies have found that flavonolignans can be
compounded with carbohydrate or lipid compounds. Synthesized silybin glycosides have
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shown to have strong antioxidant properties on hepatocytes in culture, although
antioxidant capacity was reduced compared to that of silybin. However, overall
solubility and bioavailability was greater in the glycosides than in the pure compound.
(Kosina et al., 2002) Flavonolignan glycosides may exist in the roots, stems, and leaves
of milk thistle. The improved solubility of the flavonolignan glycosides could improve
compound mobility in the plant and could concentrate in areas experiencing stress.
Similarly, flavonolignans may exist in lipid forms. Studies have shown that
flavonolignans coupled with phosphatidylcholine, a phospholipid, improved
bioavailability in the body. (Kidd and Head, 2005) Flavonolignans have also been shown
to stabilize cell membranes in the liver to prevent the entrance of toxins into liver cells.
(Fraschini et al., 2002) A similar action could occur in milk thistle cell membranes as
well, preserving membrane integrity in occurrence of stress. Unsaturated phospholipids
in cell membranes can be easily oxidized. Therefore, a lipid-bound flavonolignan could
interact with and provide antioxidant effects directly to the cell membrane.
Both of these proposed flavonolignan forms could exist in the plant and provide
an explanation of the role of flavonolignans in the plant. If these compounds did exist in
vegetative tissue, milk thistle could be grown for a short time in the basal stage, and then
vegetative growth could be bulk-harvested for flavonolignan extraction. This would
shorten the time between planting and harvesting to obtain the beneficial compounds.
Further Research
Further research should include antioxidant screenings of both lipid- and watersoluble fractions of milk thistle vegetative tissue. Also, a study should examine potential
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differences in flavonolignan profiles in plants grown in a controlled environment to
those grown in the field where UV light radiation would be high. These experiments
would greatly benefit flavonolignan production for medicinal use as well as propose a
role for flavonolignans within the milk thistle plant.
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Figure A-1: Chemical structures of silymarin components found in milk thistle
seeds.
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Figure A-2: Silybum marianum in flower in preliminary experiment. Plants are
growing in 4-inch polystyrene trays.
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Figure A-3: Effect of single leaf removal treatments on plant height in milk thistle
(Silybum marianum) seeds. Data analyzed with mixed model ANOVA. LSD means
separation shown (P<0.05).

25

A

20
B

Number
Mature Seeds

15

B

10
5
0
Basal Leaf

Cauline Leaf

No Removal

Leaf Removal Treatments

Figure A-4: Effect of single leaf removal treatments on number of mature seeds in
milk thistle (Silybum marianum). Data analyzed with mixed model ANOVA. LSD
means separation shown (P<0.05).
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Figure A-5: Effect of single leaf removal treatments on mature and total seed weights in milk thistle (Silybum
marianum). Data analyzed with mixed model ANOVA. LSD means separation shown (P<0.05).
82

16.00
14.00
12.00
Basal Leaf
Cauline Leaf
No Removal

10.00
mg compound/
8.00
g seed meal
6.00
AB

4.00
2.00

A

B
A
B

B

0.00
n
bi
ly
si
iso

B

A

in
yb
sil
iso

in
yb
sil

in
yb
sil

n
ni
ia
yd
sil

B

A

in
ist
hr
yc
sil

*
lin
fo
xi
ta

Silymarin Components

Figure A-6: Effect of single leaf removal treatments on concentrations of silymarin components in milk thistle (Silybum
marianum) seeds. Data analyzed with mixed model ANOVA. LSD means separation shown (P<0.05). * denotes
significantly affected component.
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Figure A-7: Effect of single leaf removal treatments on total levels of silymarin in milk thistle (Silybum marianum)
seeds. Data analyzed with mixed model ANOVA. LSD means separation shown (α=0.05).
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Figure A-8: Effect of single leaf removal treatments on concentrations of unknown compounds in milk thistle (Silybum
marianum) seeds. Data analyzed with mixed model ANOVA. LSD means separation are shown (α=0.05). * denotes
significantly affected unknown compounds.
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Figure A-9: Concentration of silymarin components in various sources of milk thistle (Silybum marianum) seeds. Seed
sources were as follows: F=Frontier; FO=Frontier (Organic); JS=Johnny’s Select; R=Richters Herbs; SM=Stony
Mountain Botanicals; UB=University of Belgrade; WWC=Wild Weeds (Croatia); WWO=Wild Weeds (Oregon). Seed
sources were significantly different based on mixed model ANOVA. Tukey means separation is shown at P<0.05.
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Figure A-10: Flavonolignan profile in various sources of milk thistle (Silybum marianum) seeds. Seed sources were as
follows: F=Frontier; FO=Frontier (Organic); JS=Johnny’s Select; R=Richters Herbs; SM=Stony Mountain Botanicals;
UB=University of Belgrade; WWC=Wild Weeds (Croatia); WWO=Wild Weeds (Oregon). All components were
significantly different based on mixed model ANOVA (P<0.05).
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Figure A-11: Total concentrations of silymarin in various sources of milk thistle (Silybum marianum) seeds. Seed
sources were as follows: F=Frontier; FO=Frontier (Organic); JS=Johnny’s Select; R=Richters Herbs; SM=Stony
Mountain Botanicals; UB=University of Belgrade; WWC=Wild Weeds (Croatia); WWO=Wild Weeds (Oregon). Total
concentrations were significantly different based on mixed model ANOVA. Tukey means separation is shown at
P<0.05.
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Figure A-12: Experimental design for population density effects on growing plants.
Each number represents the number of plants contained in each growth bag.

Figure A-13: One block of all population density treatments of milk thistle (Silybum
marianum) between true leaf stages 10-20.
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Figure A-14: Growth data collection and seed harvest of milk thistle (Silybum
marianum) in population density treatments in walk-in growth chamber.
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Figure A-15: Number of blooms per plant in milk thistle (Silybum marianum) grown
at different numbers of plants per container (R2=0.59). Data analyzed using
quadratic regression (P<0.05).
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Figure A-16: Bloom diameter in milk thistle (Silybum marianum) grown at different
numbers of plants per container (R2=0.72). Data analyzed using simple linear
regression (P<0.05).
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Figure A-17: Number of mature seeds in milk thistle (Silybum marianum) grown at
different numbers of plants per container (R2=0.54). Data analyzed using simple
linear regression (P<0.05).
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Figure A-18: Weight of mature seeds in milk thistle (Silybum marianum) grown at
different numbers of plants per container (R2=0.53). Data analyzed using simple
linear regression (P<0.05).
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Figure A-19: Silymarin concentration in milk thistle (Silybum marinanum) seeds from varying population densities.
Concentrations were not significant using simple linear regression at P<0.05.
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Figure A-20: Experimental design for water stress experiment. Each number
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Figure A-21: Hydroponic apparatus in greenhouse used to determine the effects of
water stress on milk thistle (Silybum marianum) plants.

95

A

120.0

A

100.0
B

B

80.0
Plant
60.0
Height (cm)

C

40.0
20.0
0.0
200

650

1100

1550

2000

mL/day
Figure A-22: Average stem height per plant in milk thistle (Silybum marianum) grown under varying daily water rates.
Data analyzed using RBD with replication model. LSD means separation is shown (significance at P<0.05).
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Figure A-23: Average bloom diameter per plant in milk thistle (Silybum marianum) grown under varying daily water
rates. Data analyzed using RBD with replication model. LSD means separation is shown (significance at P<0.05).
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Figure A-24: Average count of immature seeds per plant in milk thistle (Silybum marianum) grown under varying daily
water rates. Data analyzed using RBD with replication model. LSD means separation is shown (significance at
P<0.05).
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Figure A-25: Taxifolin concentration in primary blooms of milk thistle (Silybum marianum) grown under varying daily
water rates. Concentration is in mg of taxifolin per g of seed meal. Data analyzed using RBD with replication and
sampling model. LSD means separation is shown (significance at P<0.05).
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Figure A-26: Silymarin concentration in primary blooms of milk thistle (Silybum marianum) grown under varying daily
water rates. Concentration is in mg of taxifolin per g of seed meal. Data analyzed using RBD with replication and
sampling model. Silymarin concentrations were not significantly different at P<0.05.
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Figure A-27: Silymarin concentration in secondary blooms of milk thistle (Silybum marianum) grown under varying
daily water rates. Concentration is in mg of taxifolin per g of seed meal. Data analyzed using RBD with replication
and sampling model. Silymarin concentrations were not significantly different at P<0.05.
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Figure A-28: Aphids and whiteflies on a milk thistle (Silybum marianum) leaf in
hydroponic greenhouse production.
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Table B-1: Solvent gradient for HPLC analysis of milk thistle (Silybum marianum) seeds.
Time
Solvent A
Solvent B
(min) (CH3OH:H2O) (CH3OH:H2O)
0
85
15
5
85
15
20
45
55
35
45
55
38
0
100
43
0
100
44
85
15
Solvent A is 20% CH3OH and 80% H2O
Solvent B is 80% CH3OH and 20% H2O
Time is in minutes

Table B-2: Growth and yield parameters of milk thistle (Silybum marianum) in different single leaf removal treatments.
Removal

Stem Height
(cm)*

# Mature
Seeds*

# Immature
Seeds

Total #
Seeds*

Mature Seed
Weight (g)*

Immature Seed
Weight (g)

Total Seed
Weight (g)*

Days to
Maturity

Basal Leaf

26.0 ± 3.1 B

16 ± 8 B

8±7

24 ± 7 AB

0.399 ± 0.151 B

0.033 ± 0.043

0.432 ± 0.132 B

154 ± 1

Cauline Leaf

25.0 ± 4.5 B

13 ± 6 B

6±3

19 ± 7 B

0.319 ± 0.175 B

0.021 ± 0.027

0.340 ± 0.167 B

149 ± 10

No Removal

32.6 ± 4.2 A

22 ± 8 A

11 ± 16

33 ± 14 A

0.621 ± 0.188 A

0.034 ± 0.061

0.654 ± 0.172 A

147 ± 11

* denotes statistical significance at P<0.05 by mixed model ANOVA.
Means separation by LSD (P<0.05).
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Table B-3: Concentrations of silymarin and silymarin components in milk thistle (Silybum marianum) seeds in different
single leaf removal treatments.
Removal

Taxifolin*

Silychristin

Silydianin

Silybin A

Silybin B

Isosilybin A

Isosilybin B

Total

Basal Leaf
Cauline Leaf
No Removal

0.95 ± 0.26
0.98 ± 0.30
1.43 ± 0.21

3.31 ± 0.33
4.27 ± 0.69
4.48 ± 0.75

12.02 ± 2.80
13.46 ± 1.81
14.22 ± 1.87

1.43 ± 0.16
1.72 ± 0.23
2.19 ± 1.11

1.37 ± 0.15
1.54 ± 0.23
1.75 ± 0.71

3.61 ± 0.38
4.26 ± 0.64
4.18 ± 0.39

2.50 ± 0.29
2.83 ± 0.49
2.49 ± 0.63

25.20 ± 4.06
29.06 ± 3.97
30.73 ± 3.02

concentrations in mg of compound/g of seed meal.
* denotes statistical significance at P<0.05 by mixed model ANOVA.

Table B-4: Concentrations of unknown compounds in milk thistle (Silybum marianum) seeds in different single leaf
removal treatments.
Removal
Basal Leaf
Cauline Leaf
No Removal

Unk 2

Unk 3*

Unk 4*

Unk 6

Unk 7*

Unk 8

0.00 ± 0.00
0.11 ± 0.21
0.02 ± 0.08

1.77 ± 0.42
2.26 ± 0.46
2.58 ± 0.44

0.10 ± 0.03
0.07 ± 0.03
0.11 ± 0.03

3.28 ± 0.45
3.70 ± 0.61
3.90 ± 0.46

7.10 ± 0.83
9.13 ± 1.53
7.79 ± 1.15

0.00 ± 0.00
0.00 ± 0.00
0.23 ± 0.62

concentrations in mg of compound per g of seed meal.
* denotes statistical significance at P<0.05 by mixed model ANOVA.
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Table B-5: Concentrations of silymarin components in various sources of milk thistle (Silybum marianum) seeds.
Sources

Taxifolin

Silychristin

Silydianin

Silybin A

Silybin B

Isosilybin A

Isosilybin B

Total

F

1.32 ± 0.02

13.75 ± 0.67

4.19 ± 0.11

15.68 ± 1.32

10.89 ± 0.88

3.92 ± 0.33

1.66 ± 0.05

51.41 ± 3.34

FO

2.07 ± 0.27

6.20 ± 0.20

15.25 ± 0.15

2.97 ± 0.19

2.36 ± 0.09

3.79 ± 0.04

2.56 ± 0.09

35.19 ± 0.21

JS

1.50 ± 0.01

4.34 ± 0.54

13.91 ± 0.48

2.19 ± 0.20

1.93 ± 0.12

3.40 ± 0.24

2.34 ± 0.06

29.60 ± 1.66

R

2.18 ± 0.12

9.50 ± 0.64

5.03 ± 0.59

10.33 ± 0.69

7.36 ± 0.39

3.25 ± 0.29

1.50 ± 0.06

39.15 ± 2.79

SM

1.17 ± 0.11

15.51 ± 0.19

4.09 ± 0.49

17.33 ± 0.31

12.47 ± 0.22

4.47 ± 0.33

1.87 ± 0.37

56.90 ± 0.99

UB

0.95 ± 0.01

4.50 ± 0.25

16.50 ± 0.59

1.54 ± 0.14

1.58 ± 0.11

4.31 ± 0.33

3.07 ± 0.25

32.45 ± 1.69

WWC

1.03 ± 0.03

6.44 ± 0.11

13.41 ± 0.45

4.87 ± 0.33

3.75 ± 0.17

3.97 ± 0.03

2.39 ± 0.01

35.86 ± 0.15

WWO

1.24 ± 0.08

7.77 ± 0.10

10.03 ± 1.25

7.55 ± 0.00

5.48 ± 0.02

3.87 ± 0.22

2.29 ± 0.18

38.23 ± 1.82

Seed sources were as follows: F=Frontier; FO=Frontier (organic); JS=(Johnny’s Select); R=Richters Herbs; SM=Stony
Mountain Botanicals; UB=University of Belgrade; WWC=Wild Weeds (Croatia); WWO=Wild Weeds (Oregon).
Concentrations are in mg compound per g seed meal. All silymarin compounds were significantly affected by seed source by
mixed model ANOVA at P<0.05.
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Table B-6: Concentrations of unknown compounds in various sources of milk thistle (Silybum marianum) seeds.
Sources
Unk 2
Unk 3
Unk 4
Unk6
Unk 7
Unk 8
F
0.24 ± 0.04
2.54 ± 0.42
0.17 ± 0.01 5.79 ± 0.66 3.91 ± 0.12
5.91 ± 0.12
FO
0.14 ± 0.02
1.68 ± 0.22
0.17 ± 0.01 5.84 ± 0.04 7.55 ± 0.47
0.00 ± 0.00
JS
0.09 ± 0.13
1.81 ± 0.81
0.10 ± 0.02 3.93 ± 0.25 6.42 ± 0.79
0.00 ± 0.00
R
0.00 ± 0.00
1.66 ± 0.26
0.39 ± 0.04 4.75 ± 0.14 3.89 ± 0.47
3.28 ± 0.39
SM
0.21 ± 0.01
2.66 ± 0.00
0.15 ± 0.02 3.95 ± 0.30 4.08 ± 0.14
6.56 ± 1.50
UB
0.22 ± 0.05
2.47 ± 0.37
0.10 ± 0.04 3.78 ± 0.73 7.90 ± 0.63
0.00 ± 0.00
WWC
0.25 ± 0.06
2.10 ± 0.48
0.13 ± 0.03 4.19 ± 0.03 6.51 ± 0.20
2.20 ± 0.09
WWO
0.27 ± 0.00
1.74 ± 0.08
0.15 ± 0.03 4.13 ± 0.41 5.48 ± 0.44
2.75 ± 0.11
Seed sources were as follows: F=Frontier; FO=Frontier (organic); JS=(Johnny’s Select); R=Richters Herbs; SM=Stony
Mountain Botanicals; UB=University of Belgrade; WWC=Wild Weeds (Croatia); WWO=Wild Weeds (Oregon).
Concentrations are in mg compound per g seed meal. All unknown compounds were significantly affected by seed source by
mixed model ANOVA at P<0.05.

107

Table B-7: Growth and yield parameters of milk thistle (Silybum marianum) at different populations of plants per
container.
Plants per
Container

Blooms per
Plant*

Bloom Diameter
(cm)*

# Mature
Seeds*

# Immature
Seeds

Total #
Seeds*

Mature Seed
Weight (g)*

Immature Seed
Weight (g)

Total Seed
Weight (g)*

1

2

2.6

71

159

230

1.920

0.158

2.079

1

6

n/a

144

149

293

4.015

0.207

4.222

2

4

1.9

36

170

206

0.978

0.344

1.322

2

4

n/a

117

43

159

2.717

0.062

2.779

3

2

2.0

72

40

112

1.998

0.104

2.102

4

2

n/a

54

25

79

1.107

0.027

1.134

6

1

1.6

10

40

50

0.234

0.062

0.296

8

2

1.8

33

32

65

0.820

0.048

0.867

8

2

2.0

34

40

74

0.872

0.047

0.919

11

1

1.5

19

21

40

0.441

0.026

0.467

12

1

1.6

25

34

59

0.619

0.065

0.684

15

1

1.5

24

22

46

0.576

0.023

0.599

16

1

1.2

4

23

27

0.095

0.029

0.124

17

1

1.2

9

15

25

0.246

0.020

0.266

18

1

1.4

10

22

32

0.231

0.042

0.272

20

1

1.4

17

24

41

0.376

0.098

0.474

* denotes statistical significance at P<0.05 by simple linear regression.
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Table B-8: Concentration of silymarin and individual flavonolignans in milk thistle (Silybum marianum) seeds at
different populations of plants per container.
Plants per
Container
1
2
3
4
6
8
11
12
15
16
17
18
20

Taxifolin
2.26
2.07
2.60
2.80
1.73
2.97
2.80
3.89
2.01
2.47
2.63
3.12
18.63

Silychristin
9.68
4.59
7.54
9.32
3.66
6.78
6.41
9.49
5.82
6.58
6.21
6.95
7.87

Silydianin
0.71
8.74
4.58
1.29
5.62
3.44
1.45
2.95
5.09
6.82
5.29
4.85
3.79

Silybin A
11.48
4.68
8.58
10.74
4.35
8.80
9.86
11.55
6.97
7.51
7.56
8.62
9.40

Silybin B
7.49
3.22
5.75
7.59
2.56
5.54
6.75
7.03
4.54
5.35
5.06
5.90
6.19

Isosilybin A
2.26
2.63
2.47
2.37
1.88
2.22
2.21
2.55
2.26
2.76
2.47
2.65
2.56

Isosilybin B
0.68
1.42
1.13
0.76
0.84
0.97
0.73
0.90
1.05
1.32
1.11
1.16
1.14

Total
Silymarin
34.55
27.35
32.64
34.88
20.63
30.73
30.21
38.35
27.74
32.81
30.34
33.24
32.23

Concentration in mg compound per gram of seed meal. No flavonolignan concentrations were significant using simple linear
regression at P<0.05.
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Table B-9: Concentration of unknown compounds in milk thistle (Silybum marianum) seeds at different populations of
plants per container.
Plants per
Container
Unk 1
Unk 2
Unk 3
Unk 4
Unk 5
Unk6
Unk 7
Unk 8
1
0.02
0.26
0.99
0.07
0.04
2.03
1.30
8.87
2
0.03
0.29
1.09
0.06
0.19
3.36
2.48
1.20
3
0.05
0.33
0.99
0.06
0.28
3.13
2.10
2.22
4
0.03
0.48
1.23
0.06
0.08
2.46
1.22
2.36
6
0.04
0.25
0.80
0.06
0.01
2.67
1.44
0.87
8
0.04
0.42
1.08
0.06
0.07
2.70
1.76
1.51
11
0.04
0.38
0.91
0.07
0.00
1.95
1.28
2.77
12
0.04
0.40
1.17
0.06
0.15
3.07
1.77
2.08
15
0.05
0.46
1.11
0.05
0.10
2.73
1.86
1.57
16
0.04
0.38
1.12
0.07
0.16
3.21
2.01
1.48
17
0.04
0.38
1.17
0.06
0.17
3.30
1.86
1.40
18
0.04
0.41
1.25
0.07
0.00
3.11
1.91
1.70
20
0.04
0.42
1.23
0.05
0.17
2.78
1.92
2.30
Concentration in mg of compound per gram of seed meal. No flavonolignan concentrations were significant using simple
linear regression at P<0.05.
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Table B-10: Elemental content of fertilizer concentrate (mg/L) used to fertigate
milk thistle (Silybum marianum) in a hydroponic experiment with different water
rates.
Elements

PPM

Total N

10187.147

Ammonia N

675.559

Phosphorus

4085.55

Potassium

16407.418

Calcium

9663.236

Magnesium

5253.177

Sulfur

6592.815

Iron

208.037

Manganese

104.021

Zinc

25.994

Boron

104.021

Copper

25.99

Molybdenum

5.201

Chlorine

1040.215
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Table B-11: Six yield parameters of milk thistle (Silybum marianum) at different daily water rates.
Treatment
(mL/day)

Mature Seed
Count

Immature Seed
Count

Total Seed
Count

Mature Seed
Weight (g)

Immature Seed
Weight (g)

Total Seed
Weight (g)

200

274 ± 88

67 ± 49 AB1

341 ± 131

5.896 ± 2.358

0.241 ± 0.191

6.137 ± 2.537

650

305 ± 197

62 ± 51 B

367 ± 205

7.104 ± 4.985

0.171 ± 0.207

7.275 ± 5.007

1100

657 ± 348

102 ± 73 AB

758 ± 411

15.911 ± 9.989

0.392 ± 0.353

16.303 ± 10.224

1550

643 ± 366

64 ± 37 B

708 ± 381

15.934 ± 9.969

0.241 ± 0.220

16.175 ± 10.038

2000

624 ± 568

161 ± 153 A

785 ± 681

15.527 ± 15.478

0.433 ± 0.373

15.960 ± 15.663

LSD means separation shown (P<0.05). All other parameters were not significant at P<0.05.

Table B-12: Growth data of milk thistle (Silybum marianum) at different daily water rates.
Treatment
Number of
Bloom Diameter
Stem Height
Days to
(mL/day)
Blooms per Plant
(cm)
(cm)
Maturity
200
4±3
2.3 ± 0.4 B1
40.8 ± 11.0 C
289 ± 30
650
4±2
2.5 ± 0.5 AB
68.8 ± 23.1 B
301 ± 12
1100
7±4
2.9 ± 0.5 A
104.2 ± 24.7 A
307 ± 10
1550
6±3
2.8 ± 0.4 AB
106.2 ± 18.9 A
301 ± 15
2000
6±4
2.7 ± 0.6 AB
74.3 ± 24.3 B
296 ± 25
LSD means separation shown (P<0.05). All other parameters were not significant at P<0.05.
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Appendix C: Chromatographs and DAD Spectra
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Figure C-29: Chromatograph of taxifolin standard

Figure C-30: Spectra for taxifolin standard
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Figure C-31: 3-D spectra of taxifolin standard
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Figure C-32: Chromatograph of silybin standard (with silybin A and B)

Figure C-33: Spectra for silybin A
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Figure C-34: Spectra for silybin B
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Figure C-35: 3-D spectra of silybin A
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Figure C-36: 3-D spectra of silybin B
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Figure C-37: Chromatograph of hesperetin (internal standard)

Figure C-38: Spectra for hesperetin
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Figure C-39: 3-D spectra of hesperetin
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Figure C-40: HPLC chromatograph of silymarin profile of milk thistle (Silybum marianum) grown at a density of two
plants per container. TX=taxifolin; SC=silychristin; SD=silydianin; SA=silybin A; SB=silybin B; HE=hesperetin;
ISA=isosilybin A; ISB=isosilybin B.
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Figure C-41: HPLC chromatograph of unknown compounds in milk thistle (Silybum marianum) seeds grown at a
density of two plants per container. U3=unknown 3; U4=unknown 4; U5=unknown 5; U6=unknown 6; U7=unknown 7;
U8=unknown 8.
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Figure C-42: HPLC chromatograph of silymarin profile of milk thistle (Silybum marianum) grown at a density of four
plants per container. TX=taxifolin; SC=silychristin; SD=silydianin; SA=silybin A; SB=silybin B; HE=hesperetin;
ISA=isosilybin A; ISB=isosilybin B.
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Figure C-43: HPLC chromatograph of unknown compounds in milk thistle (Silybum marianum) seeds grown at a
density of four plants per container. U1= unknown 1; U2=unknown 2; U3=unknown 3; U4=unknown 4; U5=unknown
5; U6=unknown 6; U7=unknown 7; U8=unknown 8.
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Figure C-44: HPLC chromatograph of silymarin profile of milk thistle (Silybum marianum) grown at a density of eight
plants per container. TX=taxifolin; SC=silychristin; SD=silydianin; SA=silybin A; SB=silybin B; HE=hesperetin;
ISA=isosilybin A; ISB=isosilybin B.
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Figure C-45: HPLC chromatograph of unknown compounds in milk thistle (Silybum marianum) seeds grown at a
density of eight plants per container. U1= unknown 1; U2=unknown 2; U3=unknown 3; U4=unknown 4; U5=unknown
5; U6=unknown 6; U7=unknown 7; U8=unknown 8.
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Figure C-46: HPLC chromatograph of silymarin profile the secondary blooms of a milk thistle (Silybum marianum)
plant grown at water rate of 2000 mL/day. TX=taxifolin; SC=silychristin; SD=silydianin; SA=silybin A; SB=silybin B;
HE=hesperetin; ISA=isosilybin A; ISB=isosilybin B.
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Figure C-47: HPLC chromatograph of unknown compounds in seeds from secondary blooms of a milk thistle (Silybum
marianum) plant grown at water rate of 2000 mL/day. U2=unknown 2; U3=unknown 3; U4=unknown 4; U6=unknown
6; U7=unknown 7.
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Figure C-48: HPLC chromatograph of silymarin profile the secondary blooms of a milk thistle (Silybum marianum)
plant grown at water rate of 650 mL/day. TX=taxifolin; SC=silychristin; SD=silydianin; SA=silybin A; SB=silybin B;
HE=hesperetin; ISA=isosilybin A; ISB=isosilybin B.
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Figure C-49: HPLC chromatograph of unknown compounds in seeds from secondary blooms of milk thistle (Silybum
marianum) grown at water rate of 650 mL/day. U2=unknown 2; U3=unknown 3; U4=unknown 4; U6=unknown 6;
U7=unknown 7; U8=unknown 8.

131

SA

SB
HE

SC

ISA
ISB

TX
SD

Figure C-50: HPLC chromatograph of silymarin profile of milk thistle (Silybum marianum) seeds from Frontier
Natural Products Co-op. TX=taxifolin; SC=silychristin; SD=silydianin; SA=silybin A; SB=silybin B; HE=hesperetin;
ISA=isosilybin A; ISB=isosilybin B.
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Figure C-51: HPLC chromatograph of unknown compounds in milk thistle (Silybum marianum) seeds from Frontier
Natural Products Co-op. U2=unknown 2; U3=unknown 3; U4=unknown 4; U6=unknown 6; U7=unknown 7;
U8=unknown 8.
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Appendix D: Procedures
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Procedure D-1: Seed Sterilization Procedure
1. Cheese cloth squares (approximately 6 cm x 6 cm) were cut to hold seeds in
during sterilization treatments. Squares were wrapped around seeds and secured
with a rubber band.
2. Groups of seeds were placed in beakers and covered with a 70% ethanol solution
and placed on a shaker for 2 minutes.
3. After 2 minutes, ethanol was poured off and seeds were washed with water three
times.
4. Seeds were placed back into rinsed beakers and covered with a 5% bleach
solution, containing 1% sodium dodecyl sulfate (SDS) by weight. These were
placed on the shaker for 15 minutes.
5. After 15 minutes, the bleach solution was poured off and seeds were rinsed
thoroughly with water.
6. Seeds were then lain out on paper towels to dry if in preparation for HPLC
analysis. If seeds were sterilized in preparation to be germinated for an
experiment, seeds were then placed in a beaker of hot water for 12-16 hours for
imbibition preceding germination.
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Procedure D-2: Flavonolignan Extraction from Silybum marianum for HPLC
Analysis
Procedure modified from Wallace, S., D.J. Carrier, R.R. Beitle, E.C. Clausen and C.L.
Griffis. 2003. J Nutraceut Function Med Foods. 4(2): 37-48.
1. Grind seeds in coffee mill to 20 mesh.
2. Weigh 100 mg ground seed sample into 1.5 mL amber microcentrifuge tube.
3. Add 0.5 mL (5:1, solvent: sample) petroleum ether to microcentrifuge tube.
4. Vortex.
5. Sonicate for 30 minutes.
6. Vortex.
7. Centrifuge for 10 minutes at 2000 RCF.
8. Decant supernatant.
9. Add 0.5 mL methanol to microcentrifuge tube.
10. Vortex.
11. Sonicate for 20 minutes.
12. Vortex.
13. Centrifuge for 10 minutes at 2000 RCF.
14. Decant supernatant into 15 mL test tube and cap. Protect collected supernatant
from light.
15. Repeat steps 9-15 three times.
16. Evaporate collected supernatant to dryness under N2 stream.
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17. Add 1mL methanol.
18. Add 100 µL of hesperetin internal standard (1.0 mg/mL stock solution)
19. Vortex.
Filter through 0.45µm syringe filter into amber crimp-top HPLC sample vials.
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Procedure D-3: HPLC Parameters
HPLC:
Agilent 1100 (Agilent Technologies, Santa Clara, CA)
Detector:
Diode array detector (DAD) with 3-D spectra
Column:
Luna C-18(2) (250 x 4.6 mm, 5 µm) (Phenomenex, Torrance, CA)
Column temperature:
40 C
Mobile phases:
A: 20:80 methanol: water
B: 80:20 methanol: water
Flow rate:
0.8 mL/min
Injection volume:
25 µL
Solvent gradient:
Time
(min)
0
5
20
35
38
43
44

Solvent A
(CH3OH:H2O)
85
85
45
45
0
0
85

Solvent B
(CH3OH:H2O)
15
15
55
55
100
100
15
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Procedure D-4: Determination of Flavonolignan Concentration in Silybum
marianum seeds from HPLC Analysis Data
Flavonolignan concentrations were determined using an internal standard method.
The internal standard (IS) used was hesperetin, a flavonoid common in citrus. Each
sample had 100 µL of 1.0 mg/mL hesperetin stock solution added before HPLC analysis.
The concentration (conc) of hesperetin standard in each sample was 0.091 mg/mL. After
each run, the peak areas from the sample were used to find concentration of individual
flavonolignans (flav). The following formula was used to relate flavonolignan peak area,
IS peak area, and sample weight into flavonolignan concentration:
conc = (flav peak area/IS area) * RF * (1000/sample weight)
RF is the retention factor of each flavonolignan compound to compensate for
variation in DAD detection between the internal standard and flavonolignan compounds.
This was determined for the silybin A & B standard and the taxifolin standard. All other
flavonolignans were calculated using the RF from taxifolin.
(flav standard conc)/(flav peak area) * RF = (IS conc)/(IS peak area)
Individual flavonolignan identification was accomplished by comparing sample
peak retention times to retention times of pure standards. Pure standards used were
taxifolin, silybin A & B, silydianin, and a silymarin mixture. Taxifolin, silybin, and
silymarin standards were obtained from Sigma-Aldrich (St. Louis, MO). Silydianin was
obtained from ChromaDex (Irvine, CA). Previously published chromatographs also
assisted in conformation. (Wallace et al., 2003)
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Peak areas were established using manual, base-line integration. 3-D spectra of
standards and samples assisted in determining peak separation.
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Procedure D-5: Hesperetin Internal Standard Preparation
These various concentrations of the internal standard were run when deciding
how much of the internal standard should be added to each sample. The peak size of the
internal standard should be on a similar scale as the peak sizes of the compounds of
interest. For flavonolignan analysis, 100 µL of 1.0 mg/mL hesperetin stock solution was
added to each milk thistle seed sample for an internal standard concentration of 0.091
mg/mL in each sample.

1 µg/µL to 0.01 µg/µL (from Wallace et al. 2003)
1.0 mg/mL
0.5 mg/mL
0.1 mg/mL
0.05 mg/mL
0.01 mg/mL
1.0 mg/mL
Weigh 10mg hesperetin into 10mL volumetric flask.
Add ~ 5mL deionized (di) water.
Sonicate to dissolve any solids.
Fill to line.
0.5 mg/mL
Pipette 1mL of 1.0mg/mL solution into clean glass vial. Add 4mL di water
0.1 mg/mL
Pipette 1mL of 0.5mg/mL solution into clean glass vial. Add 4mL di water
0.05 mg/mL
Pipette 1mL of 0.1mg/mL solution into clean glass vial. Add 4mL di water
0.01 mg/mL
Pipette 1mL of 0.05mg/mL solution into clean glass vial. Add 4mL di water
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